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Systematic Study of the Synthesis of Macrocyclic Dipeptide
/3-Turn Mimics Possessing 8-, 9-, and 10- Membered Rings by
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A systematic study was performed to establish general synthesis protocols for forming enantio
mencally pure macrocyclic dipeptide lactams. Focusing on macrocycles of 8-, 9-, and 1O-membered
rings, effective syntheses were achieved by a sequence featuring peptide coupling of allyl- andhomoallyl-glycine building blocks followed by ring-closing metathesis. The 8-membered lactampossessing cis-amide and cis-olefin geometry as well as 9- and 1O-membered lactams having trans
amide and trans-olefin configurations were effectively prepared by a general strategy employingthe respective protected dipeptide, the first generation Grubbs’ catalyst, and temporary protection
of the central amide as a benzyl derivative.
Introduction
,i3-turns in peptides and proteins are of interest because
oftheir structure and biological activity.’ Polar in nature,
these secondary structures generally occupy the surfaces
of protein molecules, where they are involved in recogni
tion and binding.2 f3-turns have also been shown to be
important for receptor affinity in biologicaUy active
peptides, such as somatostatin,3 MSH,4 bradykinin,5 and
(1) fa) Venkatachalam, C. M. Biopotymers 1968, 6, 1425. (b) Suat,K. K.; Seetharama, D. S. J. Curr. Pharm. Des. 2003, 9, 1209.(2) fa) Wilmot, C. M.; Thomton, J. M. J. Mot. Biot. 1988,203, 221.(b) Lewis, P. N.; Momany, F. A.; Scheraga, H. A. Froc. Natt. Acad.Sci. U.S.A. 1971, 68, 2293.
(3) (a) Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Salvino, J.;Leahy, E. M.; Sprengler, P. A.; Furst, G.; Smith, A. B.; Strader, C. D.;Casieri, M. A.; Candelore, M. R.; Donaldson, G.; Maechler, L. J. Am.Chem. Soc. 1992, 114, 9217. (b) Veber, D. F.; Freidinger, R. M.; Perlow,D. S.; Palevida, W. J., Jr.; Holly, F. W.; Strachan, R. G.; Nutt, R. F.;Arison, B. H.; Homnick, C.; Randail, W. C.; Glitzer, M. S.; Saperstein,R.; Hirschmann, R. Nature 1981, 292, 55.(4) ta) Lee, J. H.; Lim, S. K; Huh, S. H.; Lee, D.; Lee, W. Eur J.Biochem. 1998, 51, 251. (b) Zhang, J.; Xiong, C.; Ying, J.; Wang, W.;Hruby, V. J. Org. Lett. 2003, 5, 3115.
(5) (a) Miskolzie, M.; Yamamoto, H.; York, E. J.; Stewart, J. M.;Kotovych, G. J. Biomot. Struct. Dyn. 2000, 17, 947(b) Sejbal, J.; Cairn,J. R.; Stewart, J. M.; Gara, L.; Kotovych, G. J. M&1. Chem. 1996, 39,1281.
LHRH.6 Mimics of ,i3-turns are thus desirable tools for
studying the structure—activity relationships responsible
for protein and peptide biology.7
Strategies to design 3-turn mimics have often con
strained the peptide backbone dihedral angles. For
example, fused bicyclic systems, such as azabicyclo[X,Y,OJ
alkanone amino acids 1—4, of varying ring sizes have
been used as rigid dipeptide surrogates7 that structurally
constrain three contiguous dihedral angles, k, i/’, and v,
of a fl-turn segment within the body of the heterocycle(Figure 1). Conformational analysis of bicyclic lactams
1—4 has demonstrated their propensity to favor type II
and II’ j3-turns8’9 contingent on their stereochemistry, as
evident from X-ray diffractometry, IR, and NMR spec
troscopy as well as theoretical calculations.’° Because
differences in the type II turn dihedral angle have been
(6) Freidinger, R. M.; Veber, D. F.; Perlow, D. S.; Brooks, J. R.;Saperstein, R. Science 1980, 210, 656.
(7) ta) Hanessian, S.; McNaughton-Smith, G.; Lombart, H. G.;
Lubell, W. D. Tetrahedron 1997, 53, 12789. (b) Cluzeau, J.; Lubeil, W.D. Biopotymers (Peptide Sci.) 2005, in press.(8) Halab, L.; Gosselin, F.; Lubeil, W. D. Biopolymers (Peptide Sci.)2000, 55, 101.
(9) Gillespie, P.; Cicariello, J.; Oison, G. L. Biopotymers (Peptide Sci.)1997, 43, 191.
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FIGURE 1. Representative fl-tum structure as well as bicyclic
and macrocyclic constrained dipeptide fl-tum mimics.
observed after variation ofthe ring sizes in these bicyclic
mimics, application of sets of related azabicycloalkane
amino acids lias thus proven effective for studying the
effect ofturn geometry on the biological activity of native
peptides.”’2
Alternative scaffolds are needed to cover a wider range
of turn geometries in order to better mimic natural
diversity and to enhance success in peptide mimicry.
Macrocyclic dipeptide lactams of 8-, 9-, and lO-members
have been less welI investigated relative to their bicyclic
cousins, in part due to the difficulties inherent in
synthesizing such medium-sized ring systems.13
The syntheses ofeight-membered macrocycles, such as
5, have been accomplished by ring-closing metathesis.
Constrained dipeptides (8,8)-5 and (R,S)-5, (R = Ac, X
= NHMe) were shown to adopt conformations similar to
an ideal type VIa j3-turn, as demonstrated by NMR
JOC Article
spectroscopy and the X-ray crystal structure of (S,S)-5.’
Although the type VI j3-turn did not possess proline, the
eight-membered macrocycle forced the amide between the
i + 1 and i + 2 residues to adopt the cis-isomer geometry,
as illustrated by X-ray structural analysis, which also
revealed a cis-olefin in a folded twist-boat-boat conforma
tion.14 The saturated analogue of eight-membered lactam
(R,R)-5 possessed a cis-amide geometry and type Wb
/3-turn conformation; however, dimerization took place
over time in solution and in the solid state, as revealed
by NMR dilution experiments and X-ray crystallographic
studies.15”6 Their cis-amide geometry and their propen
sity to favor type VI j3-turns makes eight-membered
lactams (5) structurally comparable to other type VI
3-turn mimics, such as 5-tert-butylproline-containing
peptides.”
Among the few syntheses ofnine-membered macrocyle
dipeptide lactams, an Ugi-multicomponent reaction fol
lowed by ring-closing metathesis has been used to
prepare tmsaturated nine-membered lactam 6 (R1 Cil3-
CO, R2 = PhCH2, X = OEt), albeit as a racemic isomeric
mixture.’8 The ring geometry and conformational prefer
ences ofnine-membered macrocyclic lactams such as 6—8
have, however, yet to be characterized.
The 10-membered macrocycle dipeptide lactam (9, R
= Boc, X = OMe) has also been synthesized by ring
closing metathesis and shown to possess a trans-olefin
geometry and çb, ip, and w torsional angles similar to that
of an ideal type I j-turn, as demonstrated by X-ray and
NMR analyses.’9
With the precedent that 8- and 10-membered macro
cyclic peptide lactams adopted type VI and type I /3-turns,
respectively, and with potential for their nine-membered
counterparts to serve similarly as turn mimics, we sought
to develop n general means for constructing the set of
heterocyclic dipeptides (5 and 7—9, R = Boc or Fmoc, X
= OH). We envisioned that this set will serve in studies
of biologically active peptides as well as intermediates
for trans-annular cyclizations to prepare azabicyclo
DÇY,0]alkanone amino acids related to 1—4.
Medium-sized macrocyclic lactams of 8-, 9-, and 10-
members have been traditionally harder to form than
their smaller and larger-sized counterparts;’3 however,
ring-closing metathesis has significantly advanced their
synthesis. For example, N-alkyl lactams of 6—10 mem
bers have been prepared by RCM.2° Transient N-alkyla
tion of the central amide with a 2,4-dimethoxy benzyl
group (Dmb) was also shown to be essential to favor a
cis-amide geometry and facilitate metathesis in the
synthesis of eight-membered lactams (5)14,15 Moreover,
(14) Creighton, C. J.; Leo, G. C.; Du, Y.; Reitz, A. B. Bioorg. lied.
Chem. 2004, 12, 4375.
(15) (a) Derrer, S.; Davies, J. E.; Holmes, A. D. J. Chem. Soc., Perkin
Trous 1 2000, 2943. (b) Creighton, C. J.; Reitz, A. B. Org. Lett. 2001,
3, 893.
(16) Derrer, S.; Davies, J. E.; Holmes, A. D. J. Chem. Soc., Perkin
Trans 1 2000, 2957.
(17) fa) Halab, L.; Lubeil, W. D. J. Ani. Chem. Soc. 2002, 124, 2474.(b) Halab, L.; Lubel, W. D. J. Org. Chem. 1999, 64, 3312.(18) Banfi, L.; Basso, A.; Guanti, G.; Riva, R. Tetrahedron Lett. 2003,
44, 7655.
(19) Fink, B. E.; Kym, P. R.; Katzenellenbogen, J. A. J. Am. Chem.
Soc. 1998, 120, 4334.
(20) Hofmann, T.; Waibel, R.; Gmeiner, P. J. Org. Chem. 2003, 68,62.





















(10) fa) Belvisi, L.; Gennari, C.; Mielgo, A.; Potenza, D.; Scolastico,
C. Eur. J. Org. Chem. 1999, 389. (b) Belvisi, L.; Gennari, C.; Madder,A.; Mielgo, A.; Potenza, D.; Scolastico, C. Eur. J. Org. Chem. 2000,695. (e) Belvisi, L.; Bernardi, A.; Manzoni, L.; Potenza, D.; Scoastico,
C. J. Org. Chem. 2000, 65, 2563.
(11) Halab, L.; Becker, J. A. J.; Darula, Z.; Tourwe, D.; Kieffer, B.L.; Simonin, F.; Lubeli, W. D. J. Mcd. Chem. 2002, 45, 5353.(12) Belvisi, L.; Bemardi, A.; Checchia, A.; Manzoni, L.; Potenza,D.; Scolastico, C.; Castorina, M.; Cupefli, A.; Giannini, G.; Carminati,
P.; Pisano, C. Org. Lett. 2001, 3, 1001.
(13) fa) illurninati, G.; Mandolini, L. Acc. Chem. Ses. 1981, 14, 95.(b) Evans, P. A.; Holmes, A. B. Tetrahedron 1991, 47, 9131.
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SCHEME 1. General Scheme for the Syirthesis of
Macrocyclic Dipeptides
j j] Peptide [j JJ
+
Coupling t)m (1
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P = Protecting Group m 1 or 2
n 1 or2
R H orAlkyl
RCM has been used effectively to make larger ring
systems that have constrained peptide conformations.21
Considering these resuits and the need for material
on n suitable seule and in a protected form for peptide
synthesis, we undertook n detailed study to prepare
macrocyclic dipeptide lactams of 8—10 members by a
general strategy featuring RCM (Scheme 1).
Resuits and Discussion
Dipeptide Precursor Synthesis. The construction
of 8-, 9-, and 10-membered ring sizes necessitated the
synthesis and coupling of allylglycine and homoallylgly
cine units prior to RCM. Allylglycine had been synthe
sized by a variety of ;nethods;22 however, our expertise
with Œ-tert-butyl N-(PhF)aspartate fl-aldehyde (10, PhF
= 9-phenylfluren-9-yl)23 served as motivation to employ
this chiral educt in the synthesis of allylglycine (Scheme
2). Aldehyde 10 was synthesized on a 7-g scale from
aspartic acid %3b,24 in five steps and 47% overali yield.
N-(PhF)Allylglycine tert-butyl ester 11 was obtained in
95% yield from the Wittig reaction of aldehyde 10 and
the yiide generated from treatment of methyltriph
enyiphosphonium bromide with MIMDS in THF.25 Ai
lylglycine hydrochionde 12 was quantitatively prepared
from the treatment of 11 with TFA, which cieaved both
Kaui et aL

















SCHEME 3. Synthesis of Homoallylglycine
Components 16 and 17
Ref27
RHNCO2Me
1a R = Bac






the tert-butyl ester and PhF groups, followed by conver
sion ofthe trifluoroacetate sait to the hydrochioride using
aq HC1 and lyophiiization. N-(Boc)- and N-(Fmoc)allyig
lycines 13a and 13b were then prepared by the protection
of 12 with (Boc)aO26L and FmocOSu,26b respectively, under
basic conditions. Allylglycine methyl ester hydrochioride
14 was quantitatively obtained by the treatment of 12
with methanoi and thionyl cifioride. The higher N-(Boc)
and N-(Fmoc)-protected homologues (homoallylglycines
16a and 165) were synthesized respectiveiy in five steps
from serine using reported procedures (Scheme 3)27
Briefly, serine was converted to its methyi ester hydro
chloride, which was protected using Boc2O or FmocOSu
and transformed to N-(Boc)- or N-(Fmoc)iodoalanine
methyl ester using iodine, PPh3, and imidazole.28 The
iodide vas then converted to a zincate and coupled to
allyl chloride
(26) fa) Tarbeli, D. S.; Yamarnoto, Y.; Pope, B. M. Froc. Natt. Acad.
Sci., U.S.A. 1972, 69, 730. (b) Paquet, A. Can. J. Chem. 1982, 60, 976.(27) Rodrfguez, A.; Miller, D. D.; Jackson, R. F. W. Org. Biomot.
Chem. 2003, 1, 973.















16a R = Boc (97%)
16b R = Fmoc (95%)
(21) fa) Trinka, T. M.; Grubbs, R. H. Ace. Chem. Res. 2001, 34, 18.
(b) Grubbs, R. H.; Blackwell, H. E. Angew. Client., Int. Ed. 1998, 37,
3281. f e) Ripka, A. S.; Bohacek, R. S.; Rich, D. H. Bioorg. Mcd. Chem.
Lett. 1998,8,357. f d) Stymiest, J. L.; Mitcheli, B. F.; Wong, S.; Vederas,
J. C. Org. Lett. 2003,5, 47. (e) Reichwein, J. F.; Versluis, C.; Liskamp,
R. M. J. J. Org. Che,n. 2000, 65, 6187. (f) Schafmeister, C. E.; Po, J.;
Verdine, G. L. J. Am. Chem. Soc. 2000, 122, 5891.
(22) (a) Xu, P-F.; Lu, T.-J. J. Org. Chem. 2003, 68, 658. f b) Nhjera,
G. G. A. C. J. Org. Chem. 2000, 65, 7310. (e) Myers, A. G.; Gleason, J.
L Org. Synth. 1999, 76, 57. f d) Yeh. T-L.; Liao, C-C.; Uang, 9.-J.
Tetrahedron 1997, 53, 11141. f e) Katagiri, N.; Okada, M.; Morishita,
Y.; Kaneko, C. Tetrohedron 1997, 53, 5725. fI) Hanessian, S.; Yang.
R-Y. Tetrohedron Lett. 1996, 37, 8997. (g) Workrnan, J. A.; Garrido,
N. P.; Sancon, J.; Roberts, E.; Wessel, H. P.; Sweeney, J. B. J. Am.
Chem. Soc. 2005, 127, 1066.
(23) fa) Gosselin, F.; Lubeil, W. D. J. Org. Client. 1998, 63, 7463.(b) Swarbrick, M. E.; Gosselin, F.; Lubeli, W. D. J. Org. CItent. 1999,
64, 1993.
(24) Gmeiner, P.; feidman, P. L.; Chu-Moyer, M. Y.; Rapoport, H.
J. Org. Chem. 1990, 55, 3068.
(25) Douat, C.; Heitz, A.; Martinez, J.; Fehrentz, J. A. Tetralredron
Lett. 2001, 42, 3319.
3840 J. Org. Chem., Vol. 70, No. 10, 2005
Synthesis of Macrocyclic Dipeptide /3-Turn Mimics







using CuErDMS. N-(Boc)amino ester 15a was hydro
lyzed with LiOH and deprotected with 50% TFA in CH2-
Cl2 to provide N-(Boc)homoallylglycine 16a and homoallylglycine methyl ester trifluoroacetate 17, respectively,
as components for peptide coupling. N-(Fmoc)Homoallylglycine 16h was obtained by hydrolysis of N-(Frnoc)
amino ester 15b using 0.8 M calcium chloride and 0.5 M
sodium hydroxide in iPrOHIH2O (7:3).29
Considering that rotation around the amide bound
would influence the rate of RCM of the dipeptides, we
synthesized an array of secondary benzyl amino esters
to prepare tertiary amides having a lower barrier for
isomerization about the amide bond (Scheme 4). Thishypothesis was supported by earlier studies of the
synthesis of eight-membered lactams that demonstrated
the utility of the acid labile 2,4-dirnethoxybenzyl (Drnb)group in the RCM step)5b The related 2-hydroxy-4-
methoxybenzyl (11mb) group lias been used to surmountdifficuit couplings in solid-phase peptide synthesis,3° and
we envisioned that secondary amino esters bearing this
group could have better reactivity than their Dmb
cousins. Similary, the 2-hydroxy-6-nitrobenzyl (Hnb)group vas considered as a photocleavable protection
reported to favor coupling by O to N acyl transfer in a
similar way as the Hmb auxiliary.3’ Reductive amina
tions of imine prepared with the respective benzaldehyde
and allyl and homoallylglycine methyl esters (14 and 17)
were performed using NaBH(OAc)3 to furnish Dmb-,
11mb-, and Hnb-protected amino esters 18 and 19 in
yields varying between 52% and 79%.
Coupling of the Fragments. The set of dipeptides
21a—23a was assembled flrst by combining allylglycine
and homoallylglycine methyl ester salts 14 and 17 as
amine components and N-(Boc)aIIyl and N-(Boc)homoallylglycines 13a and 16a as acid components using TBTU
as the coupling agent in 85—87% yields (Table 1).Coupling 0f the Dmb secondary amino esters proved moredifficuit, and many coupling conditions were tned;32
however, only HATU as the coupling agent with N
ethylmorpholine as the base was found to be effective for
making N-Boc-protected dipeptides 20h—23h bearing a
(29) Pasca), R.; Sola, R. Tetrahedron Lett. 1998, 39, 5031.(30) Johnson, T.; Quibeli, M.; Sheppard, R. C. J. Pept. Sci. 1995, 1,
JOC Article
2,4-dimethoxybenzyl tertiary amide bond in yields vary
ing between 71% and 86%. Changing from Boc protection
to Fmoc did not affect coupling, and dipeptides 21e and
22e were obtained in 85% and 82% yields, respectively.
The use of HATU could be avoided by employing N(Hmb)homoallylglycine methyl ester 19h and the sym
metrical anhydride generated from N-(Boc)homoallylg
lycine 16a, respectively, in situ to furnish 23c in 86%
yields. Attempts to apply the symmetrical anhydride
conditions using N-(Hnb)allylglycine 18h gave 22d in
87% yield; however, this route was not pursued further
because of the difficulties in making the requisite 2-hy-
droxy-6-mtrobenzaldhyde.33
Ring-Closing Metathesis. The importance ofthe rate
of amide bond isomerization on the ring-closing metath
esis was realized in the synthesis of nine-membered
macrocyles, which could not be formed without a tertiary
amide. When cyclization by olefin metathesis was exam
ined on dipeptides bearing no benzyl group at the amide
nitrogen, secondary amides 21a and 22a failed to cyclize
using both the first and second generation Grubbs’
catalyst in a variety of solvents at reflux and room
temperature. Dipeptide 21a also did not cyclize to a fine
membered ring in the presence of Ti(O-iPr)4, which has
been used previously to prevent the formation ofa cyclic
chelate between the catalyst and an amide.34 As Te
ported,’9 10-membered macrocyclic dipeptide 27a was
formed on cyclization of dipeptide 23a using the first
generation of Grubbs’ catalyst at high dilution (0.7 mM).
Macrocycles of eight and nine members were synthe
sized from dipeptides bearing only a benzyl group on the
nitrogen of the amide. Dmb-analogues 20b, 21h and e,
22h and e, and 23h reacted with the first generation
Grubbs’ catalyst to provide 8—10 membered macrocycles
24a, 25h and e, 2Gb and e, and 27h, respectively, in 71—
81% yields (Table 2). The 10-membered macrocyle (27h)
was formed in 87% yield from tertiary amide 23h
employing the same conditions used to cyclize secondary
amide 23a at a concentration four and a half limes
higher. The phenol of the 11mb group was also tolerated
by the catalyst, and 10-membered macrocyle 27e was
prepared in 86% yield. The tertiary amide facilitated
amide bond rotation and favored conformers in which the
ring-closing metathesis was possible. In the smaller-ring
cases, without the benzyl group, the cis-amide isomer was
disfavored energetically, and the barrier for isomerization
was higher such that macrocylization was inhibited.
The Dmb and 11mb groups were reported to be easily
cleaved under acidic conditions.30’35 However, N-Boc








18a m = 1, R Dmb(74%)
18b m 1, R Hnb (52%)
19a m = 2, R Dmb (70%)





(31) Miranda, L. P.; Meutermans, W. D. F.; Smythe, M. L.; Alewood,P. F. J. Org. Chem. 2000, 65, 5460.
(32) Couplings were unsuccessful using (a) TBTUIDIEAIDCM,Knorr, R.; Trzeciak, A.; Bannwarth, W.; Gillessen, D. Tetrahedron Lett.1989, 30, 1927. (b) BOPCWDIEAICH2C12, Castro, B.; Dormoy, J-R.;Evin, G.; Selve, C. Tetrahedron Lett. 1975, 1219. (e) HBTUmIEA/CH2-CI2, Dourtoglou, C.; Ziegler, J. C.; Gross, B. Tetrahedrori LeIt. 1978,1269. (d) DCCJHOBTIDIEAJCH2CI2, Sheehan, J. C.; Mess, G. P. J. Am.Chem. Soc. 1955, 77, 1067; Konig, W.; Geiger, R. Chem. Ber. 1970,103, 788.
(33) Harayama, T.; Nakatsuka, K.; Nishioka, H.; Murakami, K.;Ohmori, Y.; Takeuchi, Y.; Ishui, H.; Kenmotsu, K. Heterocyctes 1994,38, 2729.
(34) Fûrstner, A.; Langemann, K J. Am. Chem. Soc. 1997, 119,9130.
(35) Schlessinger, R. H.; Bebernitz, G. R.; Lin, P.; Poss, A. J. J. Am.Chem. Soc. 1985, 107, 1777.
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27b and e bearing 0mb and Hmb groups were recovered
as deprotected amines without the loss of the benzyhc
tertiary amide after prolonged treatment with 50% TFA
in CH2C12. Mternatively, both the Boc and Dmb groups
were removed upon exposure of eight-membered lactam
24a to the same TFA in CH2C12 conditions as reported.15b
In contrast to the N-Boc-protected lactams, N-Fmoc
protected lactams 25c and 26e were quantitativey
converted in 30 min to their secondary amide derivatives
28 and 29 by treatment with 50% TFA in CH2C12
(Scheme 5). This behavior confirms the hypothesis36 that
difficulties in cleaving 0mb groups are due to the
formation of a neighbonng positively charged ammonium
ion upon deprotection of the Boc moiety, which inhibits
protonation of the amide and shuts down the reaction.
Conversion ofN-Boc-protected macrocycles 25b and 26h
to N-Fmoc-derivatives 25c and 26e gave average yields
of 35—45%, illustrating an advantage in starting with
N-Fmoc-protected amino acids. Finally, esters 28 and 29
were hydrolyzed using 0.5 M NaOH and 0.8 M CaC12 in
iPrOHlwater (7:3) to obtain the protected amino acids
(30 and 31) suitable for incorporation into peptides by
coud-phase synthesis.29
SCHEME 5. Synthesis of Macrocycle









Reagents and conditions: (a) 50% TFNCH2C12; (b) FmocOSu,
Na2CO3, acetone/H20; (c) 0.8 M CaC12IO.5 M NaOH, i-PrOHJH2O.
The olefin geometry vas determined based on the
vicinal coupling constant ofthe vinyl protons. In the case
of eight-mernbered lactam (S, 5)-5, a coupling-constant
value of 10.4 Hz was observed and assigned to cis-olefin
JOCArticle








acid m P amine n R conditions” amide yield f %)
13a 1 Boc iSa 1 Dmb A 20h 7113a 1 Boc 17 2 H B 21a 8613a 1 Boc 19a 2 0mb A 21h 8613b 1 Fmoc 19a 2 Dmb A 21c 8516a 2 Boc 14 1 H B 22a 85lOa 2 Boc 18a 1 0mb A 22h 8116b 2 Fmoc iSa 1 0mb A 22c 8216a 2 Boc lSb 1 Hnb C 22d 8716a 2 Boc 17 2 H B 23a 8716a 2 Boc 19a 2 0mb A 23h 7416a 2 Boc 19h 2 11mb C 23c 86
“ Condition A: HATU, N-ethylmorpholine, CH2CI2, rt; condition B: TBTU, OIEA, CH2CI2, rt; condition C: symmetric anhydride, benzylic
amino ester, CH2C12, rt.
TABLE 2. Macrocycle Formation
PCy3
II 1 20 moI % CI.Ph
)m q-5 PCy3 ([1m
PHN”...N2’CO2Me CH2CI2, reflux PHN”...N CO2Me
O R O R
amide P m n R macrocycle yieM t%)
20h Boc 1 1 0mb 24a 78
2m Boc 1 2 H 25a O
21h Boc 1 2 0mb 25h 8021e Fmoc 1 2 0mb 25c 7522a Boc 2 1 H 26a O22h Boc 2 1 0mb 26h 81
22e Fmoc 2 1 0mb 26c 7123a Boc 2 2 H 27a 7723b Boc 2 2 0mb 27h 8723e Boc 2 2 11mb 27c 86
25b mml n = 1




25cm = 1, n 1
26c m = 2, n = O
4a
30m 1, n = 1
31 m = 2, n = O
(36) Dinsmore, C. J.; Bergman, J. M.; Bogusky, M. J.; Cuiherson, J.
C.; Hamilton, K A.; Graham, S. L. Org. Lett. 2001, 3, 665.
28m = 1, n = 1
29m = 2, n O
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geometry. In the case of 9- and 1O-membered lactams
7—9, coupling-constant values ranged from 18.5 to 19.1
Hz and were assigned to trans-olefins.
The amide isomer geometry of 8- and 10-membered
lactams 5 and 9 were assigned cis and trans, respectively,
based on analogy to literature compounds 514 and 9,19
for which X-ray structures were obtained. The assign
ment ofthe amide isomers of nine-membered lactams 30
and 31 was made based on 2D NMR experiments.
Initially, COSY spectra of 30 and 31 were performed in
pyridine-d5 and CDC13, respectively, to assign the protons
for each compound. Subsequently, NOESY spectra were
performed to measure long-distance transfers of magne
tization. In the NOESY spectrum of both 30 and 31, no
transfer of magnetization between the O’H protons was
observed using a variety of mixing times. Because an
amide cis isomer would be expected to exhibit strong
NOE between the neighboring Ct1H protons, the lack of
such a transfer of magnetization leads us to assign the
amide trans isomer geometry for 30 and 31.
Conclusions
A general methodology has been developed for synthe
sizing enantiomerically pure 8-, 9-, and 1O-membered
macrocyclic dipeptides. This methodology lias provided
the first syntheses of nine-membered lactams 7 and 8,
as well as a more practical route for making 10-
membered lactam 9. The importance of transient N
alkylation of the central amide was demonstrated to
facilitate ring-closing metathesis, such that higher con
centrations (3.15 mM) could be used without evoking
dimer or polymer formation. As reported, the cis-olefin
geometry was fourni in eight-membered lactam 5. The
9- and 10-membered lactams (7—9) possessed trans-olefin
geometry. The amide bond geometry vas shown to be cis
in the case of 5 and trans for macrocycles 7—9. A more
detailed investigation of the conformation of 7 and 8 in
peptide analogues is presently under study. In light of
the ability of these constrained dipeptide surrogates to
adopt conformations similar to natural /3-turns, this
practical methodology should 5e of general utility for
research in peptide science and medicinal chemistry.
Experimental Section
tert-Butyl (2S)-2-[(N-(PhF)AminoJpent-4-enoate (11). A
rt solution of methyltriphenylphosphonium bromide (13.2 g,37 mmol) in THF (103 mL) was treated with a 0.5 M solution
ofKHMDS in toluene (67 mL, 33 mmol), stirred for 30 mm,
and treated dropwise with aldehyde 10 (7.64 g, 18.5 mmol,
prepared according to ref 23) in THF (103 mL) over 10 min.
The reaction mixture tvas stirred for 1 h, quenched with 200
mL of a saturated solution of NH4CI, and the phases were
separated. The aqueous layer was extracted twice with 150
mL of ft,O. The combined organic layers were washed with
brine, dried over MgSO4, filtered, and concentrated. Chroma
tography (7% ftOAdhexanes) afforded allylglycine 11 (7.22
g, 95% yield) as a clear ou: lO.l20D +163.7° (e 1.0, CHCI3), lit.37
la]200 168.7° (c 1.0, CHC13). The ‘H mal ‘3C NMR spectral data
were consistent with the literature.’7
(2S)-2-Aminopent-4-enoic Acid Hydrochloride (12).TFA (60 mL) was added dropwise to a solution of allylglycine
11 (7.22 g, 17.5 mmol) in CH2C12 (60 mL). Once the addition
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was completed, Et3SiH (7 mL, 43.8 mmol) vas added to the
solution, which was stirred for 15 h. The volatiles were
evaporated, and the residue was dissolved in 3:1 hexanes/Et20
(50 mL) and treated with 0.5 N HC1 (25 mL). The phases were
separated, and the organic layer was extracted twice with 0.5
N HC1. The combined aqueous layers were lyophulized to give
amino acid hydrochloride 12 (2.50 g, 94% yield) as a white
solid: mp 205—207 °C; ‘H NMR (CD3OD): 5.79 (m, 2H), 5.29(m, 2H), 4.06 (dcl, 1H, J 7.1, 5.1 Hz), 2.68 (m, 2H); ‘3C NMR(CD3OD): 6 169.4, 130.1, 119.7, 51.6, 34.0. MS (ESI, miz):
116.0 (MHY.
(2S)-2-[(tert-Butoxycarbonyl)aminoJpent-4-enoic Acid(13a). A 1:1 dioxanefH2O solution (33 mL) containing hydro
chloride 12 (750 mg, 4.95 mmol) was treated with NaOH (436
mg, 9.90 mrnol). Aller the NaOH dissolved, Boc,O (1.30 g, 5.94
mmol) was added to the mixture in three portions over 10 min.
The mixture was stirred for 18 h. The dioxane was removed
by evaporation. The cmde mixture was diluted with 11,0 and
acidified top11 3—4 with a 10% KHSO4 solution. This aqueous
solution was extracted with ft20 (three turnes). The combined
organic layers were washed with brine, dried over Mg804,
filtered, and concentrated to give N-(Boc)allylglycine 13a (1.03
g, 97% yield) as a thick clear oil: tct]’°o +14.5° (e 1.28, CHC13);
The 1H and ‘3C NMR were consistent with the literature.22°
HRMS calcd for C,0H,7NO4Na, 238.10498; found, 238.10538.
(2S)-2-[(9H-Fluoren-9-ylmethoxycarbonyl)amino]pent-
4-enoic Acid (135). A 1:1 acetone/H20 solution (67 mL)
containing hydrochioride 12 (1.5 g, 10 mmol) was treated with
Na,C03 (2.1 g, 20 mmol) and Frnoc0Su (3.3 g, 10 mmol). The
mixture vas stirred for 18 h at room temperature and
concentrated. The crude mixture was diluted with H,0 and
acidifled to pH 3—4 with a 10% KHSO4 solution. This aqueous
solution tvas extracted with EtOAc (three times). The combined
organic layers were washed with brine, dried over MgSO4,
filtered, and concentrated to give N-(Fmoc)allylglycine lSb(2.36 g, 70% yield): mp 134—135 °C; [j]201, +10.6° (e 0.93,
CHCI3); ‘H NMR (CD3OD): Ô 7.68 (d, 2H, J = 9.9), 7.59 (m,
2H), 7.32 (t, 2H, J 9.7), 7.23 (t, 2H, J = 9.9), 5.64 (m, 1H),
5.09 (m, 3H), 4.25 (in, 2H), 4.12 (m, 2H), 2.57 (m, 1H), 2.44
tm, 1H); ‘3C NIvIR (CD,OD): tI 175.2, 158.5, 145.3, 145.1, 142.5,
134.7, 128.8, 128.1, 126.3, 120.8, 118.7, 68.0, 55.1, 37.1; HRMS
calcd for C20H,9N0.,Na, 360.12063; found, 360.12080.
Methyl (2S)-2-Anilnopent4-enoate Hydrochloride (14).
SOC1, (0.55 mL, 19.8 mmol) was added dropwise to a solution
ofallylglycine 12 (2.0 g, 13.2 mmol) in MeOH (22 mL) at O °C.
The mixture was allowed to warm to room temperature, stirred
ovemight, mal evaporated to give methyl ester 14 (2.16 g, 99%
yield) as a white solid: mp 91—92 °C; [a1200 +8.3° (e 1.07, CH3-
OH); ‘H NMR (CD3OD): Ô 5.76 (in, 1H), 5.28 (m, 2H), 4.15(dd, 1H, J = 6.8, 5.5), 3.83 (s, 3H), 2.69 (m, 2H); ‘3C NMR(CD,OD): Ô 168.8, 130.1, 120.1, 52.1, 52.0, 34.1; HRMS (MH)
calcd for C,H11N02, 130.08626; found, 130.08636.
(2S)-2-[(tert-Butoxycarbonyl)amino]hex-5-enoic Acid(16a). A solution ofN-(Boc)homoallylglycine methyl ester (15a,
400 mg, 1.64 mmol prepared according to ref 27) in 1:1 1120/
dioxane (16 mL) was treated with LiOH-H20 (103 mg, 2.47
mmol), stirred for 3 h, and evaporated to a residue that was
partitioned between H20 (20 mL) and EtOAc (20 mL). The
aqueous phase was acidified with 0.1 M HCI to pH 4 and
extracted twice with EtOAc (20 mL). The combined organic
extracts were washed with brine, dried over MgSO4, filtered,
and concentrated to afford acid iGa (0.364 g, 97% yield) as a
colorless ou: [a]20, —1.1° (e 1.31, CH3OH); ‘H NMR (400 MHz,
CD3OD): Ô 5.82 (in, 1H), 5.03 (in, 3H), 4.08 (m, 1H), 2.15 tin,
2H), 1.88 (in, 1H), 1.73 (in, 1H), 1.44 (s, 9H); ‘3C NMR (75
MHz, CD3OD): Ô 175.2, 157.1, 137.4, 115.0, 79.4, 53.2, 31.1,
30.0, 27.7; HRMS calcd for C,,H,,NO4Na, 252.12063; found,
252.12089.
General Procedure A: Reductive Aminations. Allyl
glycine methyl ester hydrochloride 14 or homoallylglycine
methyl ester trifluoroacetate 17 (3 rnmol) was treated with
20 mL of a saturated NaHCO3 solution and extracted with 3
(37) Kaul, R.; Broullette, Y.; Sajjad, Z.; Hansford, K. A.; Lubeil, W.D. J. Org. Chem. 2004, 69, 6131.
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x 25 mL ofCH2C12. The combined organic layers were washed
with 20 mL of brine and dried over MgSO4, filtered, andconcentrated to a volume of 30 mL. The selected benzaldehydederivative (3.3 mmol) and NaBH(OAc)3 (4.5 mmol) were addedto the mixture, which was stirred for 18 h at room temperature, treated with 20 mL of saturated NaHCO3, and stirredfor 30 min. The aqueous layer was separated and washed with3 x 20 mL of CH2C12. The combined organic layers were
washed with brine, dried over MgSO4, flltered, and concentrated to a residue that was purified by chromatography.
Methyt (28)-2-[(2,4-DimethoxybenzyflaminoJpent-4-
enoate (1$a). Chrornatography of the product from 14 (20
mmol) using 30:70 EtOAdhexanes as the eluant gave iSa as
a yellow ou (74% yield): 1H NMR: ô 7.10 (d, 1H, J 7.8),6.39 (m, 2H), 5.69 (m, 1H), 5.08 (m, 2H), 3.81—3.64 (m, 11H),3.11 (t, 1H, J = 6.6), 2.39 (t, 2H, J 6.5), 2.22 (bs, 1H); 13CNMR: ô 174.8, 160.0, 158.4, 133.6, 130.2, 120.0, 117.6, 103.5,98.2, 60.0, 55.1, 55.0, 51.4, 46.8, 37.5. MS (ESI, m/z): 280.1(MH).
General Procedure B: Peptide Coupling using HATU.The selected N-protected amino acid (1.5 equiv) and N-benzylamino ester (1.0 equiv) were dissolved in CH2Cl (0.07 M),treated with N-ethylmorpholine (1.5 equiv) and HATU (1.5equiv), stirred for 24h, and diluted with water. The aqueouslayer was extracted with CH2CI2 (3 times). The combined
organic layers were washed with brine, dried over Mg804,flltered, and concentrated to a residue that was purified by
chromatography.
N-(Fmoc)-L-Allylglyeinyl.N-(2,4-dimethoxybenzyl)-L.homoallylglycine Methyl Ester (21c). Chromatography ofthe product from 13h (1.5 mmol) and 19a (1.0 mmol) using30:70 EtOAc/hexanes as the eluant gave 21c (85% yield):’HNMR: ô 7.76 (d, 2H, J = 7.5), 7.62 (dd, 2H, J 3.3, 3.4), 7.39(t, 2H, J = 7.5), 7.30 (t, 2H, J 7.4), 7.07 (cl, 1H, J = 8.0),6.40 (dcl, 2H, J 2.1, 2.3), 5.81—5.65 (m, 3H), 5.14 (m, 2H),5.05 (m, 1H), 4.98 (m, 2H), 4.67 (d, 1H, J = 15.8), 4.46—4.29(in, 3H), 4.24—4.22 (t, 1H, J = 7.1), 4.13 tin, 1H), 3.76 (s, 6H),3.57 (s, 3H), 2.59 (in, 1H), 2.45 (m, 1H), 2.11 (in, 1H), 2.03 (m,2H), 1.80 (m, 1H); 13C NMR: ô 171.6, 171.0, 160.9, 158.6,155.3, 143.7, 141.1, 137.3, 132.3, 130.2, 127.5, 126.8, 125.0,124.9, 119.8, 118.7, 115.8, 115.4, 103.5, 98.3, 66.7, 57.7, 55.2,55.0, 51.8, 50.7, 47.0, 37.8, 30.4, 28.1. MS (ESI, in/z): 635.2fMNa).
Generat Procedure C: Ring-Closing Metathesis. In aflame dried flask, dipeptide (1.0 equiv) was dissolved in dryCH2C12 (3 mM). The mixture was heated for 10 min at 35 °C,treated with bis(tricyclohexylphosphonium)benzylidine nathe
nium (W) dichioride (RuCI2(CHPh)(PCy3)2, 20 mol %), heated
at reflux for 72h, and concentrated. The crude residue waspurified by chromatography to afford the unsaturated lactam.Methyl (E, 3S, 9S)-3-N-(Fmoc)Amino-1-f2,4-dimethoxy-benzyl)-2.oxo-2,3,4,5,8,9-hexahydro-1H.Azonine-9.car-boxylate (25c). Chromatography of the product from 21c (0.4
mmol) using 20:80 EtOAcfhexanes as the eluant gave 25e (75%yield) as a brown solid: mp 96—101 °C; 1a120n —37.8° (c 0.93,CHCI3); 1H NMR: ô 7.76 (d, 2H, J = 7.5), 7.62 (d, 2H, J7.4), 7.40 (t, 2H, J 7.4), 7.30 (t, 2H, J = 7.3), 7.23(d, 1H, J
= 8.3), 6.49 (d, 1H, J = 6.6), 6.45—6.36 (m, 2H), 6.09 (dd, 1H,J = 9.1, 18.0), 5.61 (dd, 1H, J = 9.1, 18.0), 4.66—4.35 (m, 5H),4.23 (t, 1H, J 7.1), 3.79 (s, 3H), 3.77 (s, 3H), 3.46 (s, 3H),2.67 (in, 1H), 2.30—2.15 (m, 2H), 1.90 (in, 2H), 1.75—1.65 (m,2H); ‘3C NMR: ô 173.3, 170.4, 159.8, 157.4, 155.2, 143.8, 141.1,130.9, 129.9, 129.0, 127.5, 126.9, 125.0, 125.0 119.8, 117.5,104.0, 97.9, 66.8, 56.9, 55.1, 52.0, 51.7, 47.0, 39.9, 35.0, 27.8,22.0; HRMS (MH) calcd for C34H37N207, 585.25953; found,585.25918.
General Procedure D: Removal of Dmb. A stirred
solution ofFmoc-protected dipeptide lactam (0.2 mmol) in Cil2-Cl2 (8 mL) was treated dropwise witli TFA (2 mL), stirred for18 h, and evaporated to n residue that was purified by
chromatography.
Methyl (3S,9S)-3-N-(Fmoc)Amino-2-oxo-2,3,4,7,8,9-hexahydro-1H-azonine-9-carboxylate (28). Chromatography of the product from 25e (0.5 mmol) using EtOAc as the
eluant gave 28 (95% yield) as a brown gllm: ‘H NMR: ô 7.76(d, 2H, J = 7.4), 7.60 (d, 2H, J = 7.3), 7.39 (t, 2H, J = 7.4),7.30 (t, 2H, J = 7.4), 6.35 (d, 1H, J = 7.0), 6.25 (d, 1H, J11.6), 6.08 (dd, 1H, J = 8.8, 18.9), 5.65 (ddd, 1H, J 6.04,10.95, 10.84), 4.39—4.38 (in, 2H), 4.25 (m, 3H), 3.73 (s, 3H),2.70 (m, 1H), 2.30 (dd, 2H, J = 8.5, 8.7), 2.12 (in, 1H), 1.87(m, 1H), 1.75 (in, 1H); ‘3C NMR: ô 172.7, 172.0, 155.2, 143.7,143.6, 141.1, 130.1, 128.7, 127.5, 126.9, 124.9, 119.8, 66.8, 52.5,52.1, 47.0, 34.1, 33.8, 22.5; HRMS (MH)* calcd for C25H27N205,435.19145; found, 435.19184.
General Procedure E: Methyl Ester Hydrolysis. Astirred solution ofmethyl ester (0.5 mmol) in 0.8 M CaCl2 in
a 7:3 i-PrOHJH2O solution (10 mL) vas treated with 0.5 MNaOH solution (2 mL). After 2 h, ether was added, and thephases were separated. The aqueous layer was acidified with1.0 N HCI and extracted with EtOAc (three turnes). The
cornbined organic layers were washed witli brine, dried overMgSO4, filtered, and concentrated to give the acid.(E,3S,9S)-3-N-(Fmoc)Anilno-2-oxo.2,3,4,7,8,9-hexahydro-1H-azonine-9-carboxylic Acid (30). Hydrolysis of 28 (0.4
mmol) gave 30 (99% yield) as a white solid: mp 190—193 °C;
‘H NMR (400 MHz, pyridine-di): ô 8.90 (d, 1H, J = 11.0), 8.38(d, 1H, J 7.1), 7.8 (m, 3H), 7.7 (t, 1H, J = 7.5), 7.35 (in, 3H),7.25 (t, 1H, J = 9.0), 6.04 (dd, 1H, J = 8.6, 18.5), 5.75 (bs,1H), 5.56 (dd, 1H, J = 8.7, 18.5), 4.84 (t, 1H, J 7.8), 4.69 (m,1H), 4.55 (d, 2H, J = 7.16), 4.33 (t, 1H, J = 6.8), 2.95—2.88(m, 1H), 2.5 (m, 1H), 2.35 (m, 1H), 2.20 (m, 1H), 1.9 tm, 2H);
‘3C NMR: ô 175.3, 174.1, 156.7, 145.2, 144.9, 142.1, 131.5,129.3, 128.5, 127.9, 126.1, 120.8, 67.3, 52.9, 48.2, 41.4, 34.8,31.0; HRMS (MHY calcd for C2,H25N205, 421.17580; found,421.17599.
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Lubell.* Systematic Study of the Synthesis of Macrocyclic
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Page 3838, Abstract and Table of Contents. The
Abstract and Table of Contents graphic should be re




O CO2H o CO2H
Page 3838, Abstract, third sentence. The sentence
should read as follows: “The 8-membered lactam pos
sessing cis-amide and cis-olefin geometry as well as
9-membered lactams having trans-amide and cis-olefin
configurations were effectively prepared by a general
strategy employing the respective protected dipeptide, the
first generation of Grubbs’ catalyst, and temporary
protection of the central amide as a benzyl derivative.
The 10-membered macrocycle was synthesized possessing
cis- or trans-olefin geometry by ernploying similar me
tathesis conditions in the presence or absence of tempo
rary benzyl amide protection, respectively.”
Page 3839. Figure 1 should be replaced with the
revised Figure 1 shown.
Page 3839, column 1, third paragraph, second sen
tence. The sentence should read as follows: “Constrained
dipeptide (S,R)-5 (R = Ac, X = NUMe) was shown to
adopt a conformation similar to that of an ideal type VIa
/-turn, as demonstrated by NMR spectroscopy and X-ray
analysis.’4”
Page 3839, column 2, first paragraph. Line 6 reads
“twist-boat-boat” and should read “boat-boat”.
Page 3839, column 2, first paragraph, lino 7. The
sentence should rend as follows: “The saturated analogue
of 8-membered lactam tS,R)-5 vas also shown to adopt
a cis-amide type VIb fl-turn conformation by NMR,
computational, and X-ray analyses.’6”
Page 3839, column 2, second paragraph, second sen
tence. The sentence should rend as follows: “These nine
membered macrocycies were shown to possess cis-olefin
and trans-amide geometry by NMR analysis. The (S,S)
isomer of 6 (R’ = Bn, R2 = COCH2NHBoc, X = OEt) was
shown to adopt n type II’ fl-turn by computational
analysis and NMR spectroscopy.”
Page 3839, colunm 2, fourth paragraph, flrst sentence.
The sentence should read as follows: “With the precedent
that 8-, 9-, and 10-membered macrocyclic peptide lactams
adopted respectively type VI, II’, and I fl-turns, respec
tively, we sought to develop a general means for con
structing the set ofheterocyclic dipeptides 5 and 7—9 (R
Boc or Fmoc, X OH).”
FIGURE 1. Representative j9-tum structures as well as
bicyclic and macrocyclic constrained dipeptide jI-tum mimics.
Page 3839. Reference 15a should be changed to ref 16b.
Reference 18 should have the following reference added:
(b) Dietrich, S. A.; Banfi, L.; Basso, A.; Damonte, G.;
Guanti, G.; Riva, R. Org. Biomot. Chem. 2005, 3, 97.
Page 3841, column 2, third paragraph, third sentence.
The sentence shouid read as follows: “The 10-membered
macrocycle (275) was formed in 87% yield from tertiary
amide 23b employing the same conditions used to cyclize
secondary amide 23a at a concentration four and a half
times higher; however, the olefin geometry was shown
to be cia as discussed below.”
Page 3842. Table 2 and Scheme 5 should be replaced
as shown.
Page 3843, column 1, flrst sentence. The sentence
should rend as follows: “The vinyl protons of the olefin
in 9-membered lactams 25c and 31 were observed as
quadruplets; however, decoupling experiments by ir
radiation of the allylic signais at 2.70 and 2.30 ppm for
25c and at 2.69 ppm for 31 demonstrated that the vinylic
coupling constant for both compounds was 10.5 Hz
consistent with a cis-olefln. Similarly, the vinyl coupling
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amide P m n R macrocycle E/Z yield (%)
20b Boc 1 1 Dmb 24a Z 7821a Boc 1 2 H 25a O21h Boc 1 2 Dmb 25h Z 8021e Fmoc 1 2 Dmb 25c Z 7522a Boc 2 1 H 26a O22h Boc 2 1 Dmb 26b Z 8122e Fmoc 2 1 Dmb 26c Z 7123a Boc 2 2 H 27a E 7723h Boc 2 2 Dmb 27b Z 8723e Boc 2 2 11mb 27c Z 86
27b was 11.0 Hz, indicative of a cis double bond. TheX-ray structure of macrocycle 27a which was preparedfrom linear precursor 23a bearing a secondary amide hadpreviously demonstrated the presence of a trans-olefin.’9”Page 3843, Conclusions, fifth sentence. The sentence
should read as follows: “The 9-membered lactams 7 and8 also possessed cis-olefin geometry. On the other hand,
olefin geometry was contingent on the manner that 10-
membered lactams 27b and 27a were synthesized;tertiary amide 23b gave the cis-olefin and secondary
amide 23a provided trans-olefin.”
Page 3844, column 1, sixth paragraph, lime 8. Replace
“6.09 (dd, 1H, J = 9.1, 18.0), 5.61 (dd, 1H, J 9.1, 18.0)”
with “6.09 (q, 1H, J = 9.3), 5.61 (q, 1H, J 9.1)”.Page 3844, column 2, second paragraph, lime 7. Replace
“6.08 (dd, 1H, J = 8.8, 18.9), 5.65 (ddd, 1H, J = 6.04,10.95, 10.84)” with “6.08 (q, 1H, J = 9.3), 5.65 (ddd, 1H,J = 6.0, 11.0, 10.8)”.
Page 3844, column 2, fourth paragraph, lime 6. Replace
“6.04 (dd, 1H, J = 8.6, 18.5), 5.75 (bs, 1H), 5.56 (dd, 1H,J 8.7, 18.5)” with “6.04 (q, 1H, J = 9.1), 5.75 (bs, 1H),5.56 (m, 1H)”.
Page 3844. The following sentence should be added tothe Acknowledgment. “We acknowledge Professor LucaBanfi for advice concerning olefin stereochemistry.”Page 3844. The following text should be added to theSupporting Information paragraph: “decoupling experi
ments on compounds 25c and 31”.
SCHEME 5. Synthesis of Macrocycle
N-(Fmoc)-dipeptides 30 and 31
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Pages 3734—3736. The structures ofthe syn productsin the TOC, abstract, and Table 3 are incorrect. The
correct structures of syn products are shown below.Equation in TOC and abstract:













25b m 1, n = 1




30m = 1 n = 1





25e m = 1 • n = 1





28m = 1, n = 1
29m = 2, n = O
Ph—.R R R R’ R





Equation in Table 3:
R2 R’
R’ 2.Oequiv. RMgBr
3 mol % cu(OTI)2
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tonation and epimerization.6 The PhF group is usually removed
by hydrogenolysis7 and by solvolysis with treatment under
strongty acidic conditions.8 Atternativety, the Phf group has
been removed using sodium or lithium in liquid ammonia,9
TMSOTf in the presence of triethylsilane,1° and iodine in
MeOH.’t
Perceiving the advantages of having a chemical means for
rendering the PhF group cleavable under mildly acidic condi
tions, we considered that p-aminophenylfluorenyl cations would
be significantly more stable than the parent PhF cation.
Strategies have been conceived for generatingp-aminobenzylic
intermediates ftom suitable para-substituted benzyl derivatives.
For example, the p-nitrobenzyt ester has been used in the
synthesis ofcarbapenems and removed by nitro group reduction
and solvolysis.12 More recently, p-halobenzyl ethers were
reported to be as stable as normal benzyl ethers yet cleavable
using a two-step process featuring catalytic amination of the
aryl halide and solvolysis with acid.13
In our previous work, we used the 9-(4-bromophenyl)-9-
fluorenyl (BrPhF) group in a linking-protecting group strategy
for the synthesis ofenantiopure norepheddnes on solid support.’4
The BrPhF group proved toI erant to similar chemistiy previously
developed with PhF-protected amino acids before it reacted in
a palladium-catalyzed cross-coupling with bis(pinacolato)
diboron ester to give a suitable boronate for attaching the Phf
protected substrate to aryl halide resins. Pursuing the develop
ment of this protecting group, we demonstrate now that the
BrPhF group can be employed as a safety-catch’5 amine
protecting group which can be released by catalytic amination
fotlowed by treatment with mild acid.
The relative acid stability of the Phf group and an analogue
bearing ap-aminophenyl substituent was studied by the synthesis
ofN-(9-(4-morpholinophenyl)-9-fluorenyl)alanine methyl ester
2 and compaHson of its reactivity under acid conditions witb
N-(PhF)alanine methyl ester (Scheme 1, MPf 9-(4-morpholi-
nophenyl)-9-fluorenyl).
Both N-(PhF)- and N-(BrPhf)alanine methyl esters were
synthesized as previously described.’4”6 Amination ofBrPhF
Ala-OMe (1) with morpholine using 5 mol % ofPd(OAc)2, (±)-
BINAP, and excess Cs2CO3 provided N-(MPf)alanine methyl
ester (2) in 81% yield. Competitive cleavage ofN-(PhF)alanine
The 9-(4-bromophenyl)-9-fluorenyl (BrPhF) group has been
developed as a novel safety-catch amine protection. This
relatively acid-stable protecting group can be successfiully
activated by palladium-catalyzed cross-coupling reaction of
the aiyl bromide with morpholine and then cleaved ef
fectively under mild conditions using dïchloroacetic acid and
triethylsilane. Complementary conditions are reported for
selective removal ofthe BrPhF group in the presence oftert
butyl esters and carbamates as well as deprotection of tert
butyl esters and carbamates in the presence ofBrPhF amines.
Protecting groups have been essential for controlling the
reactivity of amines in organic synthesis, peptide science, and
medicinal chemistry.1’2 In the context of our research on the
synthesis of peptide mimics,3 the 9-phenyl-9-fluorenyl (PhF)
group has been used to prevent the loss of enantiomeric purity
during the employment ofvarious amino carbonyl compounds.4
The Phf group offers several advantages as amine protection.
The steric bulk created by the PhF group acts as a barrier that
prevents deprotonation of Œ-amino carbonyl compounds at the
Œ-carbon. The PhF group is significantly more stable under acid
conditions relative to the trityl group because of the anti
aromatic character of the 9-phenyl-9-fluorenyl carbocation.5
Furthermore, if deprotonation of the a-carbon occurs under
severe conditions, the PhF anion can act as a leaving group
and eliminate to fiimish an imine intermediate prior to repro
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e R=t-Bu,PHL 10 R = t-Bu, P = Boc (84%)
Key: fa) Pd(OAc)2, (±)-BINAP, Cs2CO3, morpholine, PhCH3, reflux;(b) CHCI2CO2H, Et3SIH, CH2CI2; (e) LiOH, H20/dioxane; (U) O-tert-butyltrichioroacetamidate, CH2CI2; (e) Boc2O, Et3N, CH2CI2.
methyl ester and N-(MPF)alanine methyl ester (2) was per
formed by treating an equimolar mixture ofthe protected amino
acids in CH2CI2 with trichioroacetic acid and triethylsilane.
Under these conditions, the 9-(4-morpholinophenyl)-9-fluorenyl
group was clcaved within 5 min as monitored by HPLC, which
detected 9-(4-morpholinophenyl)-9-fluorene (3). The Phf
protected methyl ester remained stable and no trace correspond
ing to PhFH was observed by HPLC. Employing the milder
dichioroacetic acid under the same conditions, complete sol
volysis ofiV-(MPF)alanine methyl ester (2) occurred within 30
min.
The selective removal of the BrPhF group from an amino
tcrt-butyl ester was next studied to establish cleaving conditions
tolerant to n more acid-labile group. N-(BrPhf)Aianine 4 was
synthesized as previottsly described by hydrolysis of methyl
ester 1 using LiOH.’4 N-(BrPhF)alanine tert-butyi ester (5) was
then prepared in 81% yield by treating the amino acid with
O-tert-butyl trichloroacetimidatet7 in dichloromethane followed
by chromatography. The conversion ofN-(BrPhf)alanine tert
butyl ester (5) to N-(MPf)alanine tert-butyl ester (6) was
achieved in 79% yield using the palladium-catalyzed reaction
conditions mentioned above. Exposure of a 1:1 mixture of
N-(PhF)alanine tert-butyl ester18 and N-(MPF)alanine tert-butyl
ester (6) to dichioroacetic acid and triethylsilane in CH2CI2
caused selective deprotection in 30 min as monitored by HPLC
which indicated the appearance of morpholine 3 and no traces
of9-phenylfluorene nor any corresponding acids after 30 min.
Treatment of N-(MPF)alanine tert-butyl ester (6) with 20 equiv
of dichloroacetic acid and 2 equiv of triethylsilane in CH2CI2
for 30 min followed by addition of 22 equiv of triethylamine
and Boc2O provided N-(Boc)alanine tert-butyl ester in 84%
yield. Altematively, alanine tert-butyl ester could be isoiated
as its tiydrochioride sait in 89% yield after MPF deprotection,
extraction with diiute aqucous HCI, and lyophilization.
To explore more deeply the strengths and limitations of this
protection group N-(BrPhf)alaninyl(a-Boc)lysinc tert-butyi
“Key; (a) DCC, HOBt, DIEA, CH2CI2; (b) Pd(OAc)2, (+)-BINAP,Cs2CO3, morpholine, PhCH3, reflux; (c) fi) CHC1CO2H, Et3SiH, CH2CI2,(ii) Et3N, CICO2Me; (d) (I) CHCI2CO2H, Et3SiH, CH2CI2, (ii) Et3N,fmocOSu.
ester (11) was synthesized by coupling acid 4 with (w-Boc)
lysine tert-butyl ester using DCC and HOBt in 75% yield(Scheme 2).
Conversion to the N-(MPF) dipeptide 12 was effected as
previously described in 78% yield. The MPF-protected amine
was selectively deblocked using CHCI2CO2H and Ft3SiK and
the free amine was subsequently converted in situ to a methyl
carbamate using methytchloroformate and Et3N in 82% yield.
The ‘H NMR spectrum ofthe crude mixture showed a one-to
three ratio of singlets corresponding to the methyl and tert
butyl protons for the carbamates indicating that no deprotection
ofthe Boc-protected amine had occurred. The LC—MS analysis
of the crude mixture also contirmed that Boc-deprotection did
not occur during the sequence. Using a similar protocol,
N-(fmoc)alaninyl(w-Boc)lysine tert-butyl ester (14) vas syn
thesized by deprotecting thc MPf-amine and reprotecting using
fmocOSu and Et3N in 86% yieid.
Selective removal of tert-butyl esters in the presence of Phf
amines bas been recently reported tu be effecfively accomplished
using ZnBr2 in CH2C12.’t When BrPhF-Ala-OtBu (5) was
submitted to these conditions, N-(BrPhF)alanine vas obtained
in 82% yield (Scheme 3). The acid stability ofthe BrPhf group
was demonstrated by the selective removal of the Boc group
using C12CHCO2H which afforded dipeptide 15 in 72% yield,
as well as by removal ofboth the tert-butyi ester and carbamate
groups using the stronger acid CI3CCO2H to give dipeptide 16
in 73% yield. These results demonstrated that the orthogonal
nature of the BrPhF/tert-Bu combination of protecting groups
can ho utilized in both directions.
In sum, we have demonstrated the utility of the 9-(4-
brornophenyl)-9-fluorcnyl group as safety-catch amine protec
tion. Similar to the Phf group, the BrPhf group may be used
to ensure the confïgurationai stability of amino carbonyl
compounds. This relativeiy acid stable group can then be
rendered susceptible to mild acid solvolysis by palladium
catalyzed amination. The potential of this slrategy bas been
iiiustrated by the palladium-mediated selective cleavage ofthe
BrPhF-amine in the presence ofthe acid labile tert-butyl ester
and carbamate groups and comptementaty removal ofeither Boc
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group or both Boc and tert-butyl ester groups in the presence
ofthe BrPhF-amine. Considering the need for setective methods
for removing acid labile protecting groups, the BrPhF group
should find general utility in the synthesis of amines.
Experimental Section
(23’)-N-(BrPhF)alanine tert-Butyl Ester (5). To a stirred
suspension of(2S)-N-(BrPhF)alanine (540 mg, 1.32 mmol, prepared
according to ref 14) in CH2C12 (4 mL) vas addcd O-rert-butyl
trichioroacetimidate (578 mg, 2.64 mmol). The mixture was stirrcd
for I day, filtered, evaporated, and resubmitted to the same
conditions as above for 2 days. Filtration and evaporation, followed
by chromatography (5% EtOAc in hexanes) gave ester 5 (495 mg,
81%) as a clear ou: [ŒF°0 —51.3 (e 1.5, CH3OH); ‘H NMR à
7.72 (U, J 7.8 Hz, 2H) 7.40—7.26 (m, 10H), 3.09 (s, 1H), 2.69(q, J 7.1 Hz, 1H), 1.23 (s, 9H), 1.13 (d, J= 7.1 Hz, 3H); ‘3C
NMR 6 175.4, 142.9, 148.6. 143.7, 140.3, 139.7, 130.9, 127.99,
127.96, 127.7, 127.6, 127.5, 125.4. 124.8, 120.7, 119.7, 119.5, 80.1,
72.3, 5 1.6, 27.5, 2 1.8; HRMS calcd for C26H27BrNO2 [M + HJ
464,1227, found 464.1219.
General Procedure for N-(1WF’)amine Synthesis. 71e BrPhf
protected amine (2.5 mmol) was dissolved in 5 mL of dry and
degassed toluene and treated tvith Pd(OAc)2 (28 mg, 0.13 mmol),
BINAP (79 mg, 0.13 mmol), and dry Cs2CO3 (4.07 g, 12.5 mmol),
followed by morpholine (257 uL. 3.0 mmol). The mixture vas
heated at reflux and stirred for 24 h, filtered on Celite, washed
with CH2C12, and the combined filtrate and washings were
evaporated. The residue was chromatographed to afford the MPF
protected amine.
(ZS)-N-(1iPF)alaninc Methyl Ester (2). Chromatography of the
product from 1(1.00 g, 2.4 mmol) using 20% EtOAc in hexanes
as eluant gave 2 (820 mg, 81% yield) as a yellowish solid; mp
62—64 °C; [a]200 —121.1 (e 2.2, CH3OH); ‘H MvIR 6 7.68 (dU, J
7.5 Hz, 2.5 Hz, 2H), 7.33 (m. 5H), 7.23 (m, 3H). 6.77 (d, J =
8.9 Hz, 2H), 3.82 (t, J 4.8 Hz, 4H), 3.30 (s, 3H), 3.10 (t, J 4.8
Hz, 4H), 2.77 (q, J = 7.0 Hz, 1H), 1.12 (d, J = 7.0 Hz, 3H); ‘3C
NMR 6 177.1, 150.1, 149.4, 148.8, 140.6. 139.9, 135.6, 128.0,
127.6, 127.2, 126.9, 125.8, 124.8, 119.8, 119.7, 115.1, 72.4, 66.7,
51.4, 51.2, 49.0, 21.4; HRMS calcd for C27H28N2O3Na [M + Na]
451.1989, fot,nd 451.1992.
Generat Procedure for MPF-Sotvolysis. The MPf-protccted
amine (0.4 mmol) was dissolved in 4 mL of CH2C12, treated with
dichloroacetic acid (660 uL, 8 mmol) and triethylsilane (128 tiL,0.8 mmol), stirred at rI for 30 mi and evaporated on a rotary
evaporator. The residue was dissolved in 10 mL of Et20 and treated
with 10 mL of 0.5 M HCI solution. 71e aqucous phase was
separated, washed twice with 5 mL of Et20, and lyophilized to
give the unprotected amine as a hydrochloride salt. Altematively.
after complete solvolysis of MPf-amine was observed by TLC,
the reaction mixture vas treated with 22 equiv of Et3N followed
by 200 mol % of either 3oc20, methyl chlorofonr,ate or FmocOSu,
stirred ovemight, diluted with CH2CI2, washed with H20, 0.5 N
HCI, and brine. dried over MgSO4, ami concentrated. The cmde
residue was purified by flash chromatography2° to give, respectively,
the Boc-, mcthyl carbamoyl- or Fmoc-protected amino ester.
(2S-AIanine tert-Butyl Ester Hydrochtoride (9). Lyophilization
ofaqueous layer after solvolysis of 6 (190 mg, 0.4 mmol) gave 9(65 mg, 89% yield) as a white solid: mp 170 C dec (lit.’9 mp 16$
C dcc); [ŒJ200 6.1 (c 1.0, EtOH) [lit.’9 [Œj20 3.0 (c 2.0,
EtOH)]; HRMS calcd for C7H,5NO2Na [M + NaJ 168.0995, found
168.0987.
N-(fmoc)alaninyl-w-(Boc)lysine tert-Butyl Ester (14). Chro
matography of the product from 12 (30 mg, 0.11 rnmol) using 30%
EtOAc/hexanes as eluant gave 14 as a white powder (22.0 mg,
86% yield): mp 67—69 °C; [Œ]20 —16.5 (c 1.0, CHCI3); ‘H NIvIR
6 7.76 (U, J = 7.5 Hz, 2H), 7.59 (d, J 7.4 Hz, 2H), 7.39 (t, J =
7.2 Hz, 2H), 7.31 (tt, J 7.5, 1.2 Hz, 2H), 6.59 (d, J 6.7 Hz,
1H), 5.59 (s, 1H), 4.69 (s, 1H), 4.45 (m, 1H), 4.38 (d, J 7.0 Hz,
2H), 4.29 (m, 1H), 4.22 (t, J 7.0 Hz, 1H), 3.06 (d, J 5.5 Hz,
1H), 1.84 (rn, 2H). 1.65 (m, 1H). 1.52—1.27 (m, 6H), 1.46 (s, 9H),
1.42 (s, 9H); ‘3CNMR6 171.8, 171.0, 156.0, 155.8, 143.6, 141.1,
127.6, 126.9, 125.0, 119.8, 82.1. 79.0, 67.0, 52.4. 50.3, 47.0, 39.9,
33.5, 29.2, 28.3, 27.8, 21.9, 18.6; HRMS calcd for C33H45N307[M + NaJ 618.31389, found 618.31389.
4-f4-(9H-fluoren-9-yl)phenylJmorpholine (3). The N-aiylamine
3 was isolated by flash chromatography as the second etuting
compound of the crude residue in the solvolysis of the MPf
protected amine 5: ‘H NMR 6 7.82 (d, J 7.5 Hz, 2H), 7.42—
7.26 (m, 6H), 7.03 (U, J 8.5 Hz, 2H), 6.84 (d, J = 8.3 Hz, 2H),
5.02 (s, 1H), 3.87 (t, J 4.8 Hz, 4H), 3.15 (t. J = 4.8 Hz, 4H);
‘3C NMR à 149.7, 147.9, 140.5, 128.7. 126.9, 126.8, 124.9, 119.4,
t 15.5. 66.6, 53.3, 49.0; MS (EST, n,/z) 328.3 (MH).
(2S)-N-(BrPhF)atanine (4). A stirred solution of N-(BrPhF)
alanine tert-butyl ester (6) (45 mg, 0.1 mmol) in 0.5 mL of
dichloromcthane was treated with ZnBr2 (110 mg, 0.5 mmol) at rt,
(19) Csanady, G.; Medzihradszky, K. Org. Prep. Proced. I,,t. 1988, 20,180—184.
(20) Still, W. C.; Kahn, M.; Mitra, A. I Org. C’hem. 1978. 43, 2923.(21) Yuste, F.; Ortiz, B.; Carrasco, A.; Peralta, M.; Quintero, L.; Sanchez
Obregon, R.; Watts, F.; Ruano, J. L. G. Tctrahedron: Asvnnnehy 2000,
II, 3079—3090.
(22) Zeggaf, C.; Poncet, J.; Jot,in, P.; Dufour, M. N.; Castro, B.
Tetraheclro,, 1989, 45, 5039—5050.
(23) Barton, D. H. R.; Herve. Y.; Potier, P.; Thieny, J. Tetrahedrou 1988,
44, 5479—5486.
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stirred for 24 h, treated with water (2 mL), stïrred for 2 h, and
trcated with CH2CI2 (5 mL). The organic phase was separated. The
aqueous layer tvas extracted twice with CH2CI2 (2 mL). The organic
portions were combined, dried, filtered, and evaporated. The residue
was chromatographed (50% EtOAc:hexanes containing t 1Y0 AcOH)
to afford 32.5 mg (82% yield) of N-(BrPhf)alanine as a white
solid: mp 116—118 °C; []20 —16.5 (e 1.1, CH3OH). The
spectroscopie data were identical b those reported.’4
N-(BrPhF)ataninyl-w-(Boc)lysine tert-Butyt Ester (11). N(BrPhF)alanine (4), (514 mg, 1.26 mmol), DCC (311 mg, 1.51
mmol), and HOBt (204 mg, 1.51 mmol) were dissolved in 13 mL
ofCH2CI2, treated with w-(Boc)Iysine terr-butyl ester (380 mg, 1.26
mmol), stirred for 24 h, ffltered, washed with a 10% HCI solution,
saturated NaHCO3, ami brine, dried over MgSO4. filtered, and
concentrated to a residue that was purifled by chromatography (50%
EtOAc/hexanes) to afford 651 mg (75% yield) of 11 as a white
powder: mp 83—$5 °C; [Œj200 —20.8 (c 1.0, CH3OH); ‘H NMR à
7.96 (d, J 7.6 Hz, 1H), 7.72 (U, J 7.5 Hz, 1H), 7.62 (d, J
7.5 Hz, 1H), 7.44—7.25 (m, 9H), 7.05 (t, J = 7.5 Hz, 1H), 4.68(m, 1H), 4.27 (q,J= 7.2 Hz, 1H), 3.10 (m, 2H), 2.47 (q,J 7.1
Hz, 1H), 2.25—1.80 (bs, 1H), 1.75 (m, 1H), 1.62 (m, 1H), 1.54 (s,
9H), 1.43 (s, 9H), 1.54—1.43 (m, 2H), 1.29 (m, 2H), 1.09 (d, J
7.1 Hz, 3H); ‘3C NMR à 175.1, 171.8, 156.1, 148.9, 147.3, 143.5,
141.4 140.0, 131.6, 128.9, 128.8, 128.2, 128.1, 127.7, 126.1, 124.3,
121.4, 120.4, 120.2. 82.2, 79.1, 73.0, 52.8. 51.9, 40.4, 33.0, 29.5,
28.5, 28.1, 22.2, 21.8; HRMS calcd for C37H46BrN3O5Na [M +
Na] 714.25131, found 714.25002.
N-(BrPhF)ataninyltysine rerr-Butyl Ester (15). N-(BrPhF)
alaninyl(w-Boc)lysine tert-butyl ester 11(50 mg. 0.072 mmol) was
dissolved in 150 L ofCH2CI2, treabed with 150 1iL of CI2CHCO2H,
and stirred for 21 h. The mixture vas dilutcd with 5 mL ofCH2-
Cl2, washed with saturated NaHCO3 (2 x 3 mL), dried over MgSO4.
concentrated, and purified by chromatography (5% MeOH/CHCI3
+ 1% Et3N) to give amine 15 (30.7 mg, 72% yicld) as a brownish
oil: [Œ]200 39.7 (c 2.6, CHC11); ‘H NMR (CD3OD) 67.80 (d, J =
7.5 Hz, 1H), 7.73 (d, J 7.5 Hz, 1H), 7.46—7.26 (in, 9H), 7.08(dt, J 1.0, 7.6 Hz. 1H), 4.06 (m, 1H), 2.90 (m, 2H). 2.44 (q, J
Toc Note
7.1 Hz, 1H), 1.73 (m. 1W), 1.64 (m, 3H), 1.53 (s, 9H), 1.29 (m,
2H), 1.08 (d. J = 7.1 Hz, 3H); ‘3C NMR (CD3OD) à 178.6, 172.5,
150.5. 149.3, 145.3, 142.4, 141.6, 132.3, 129.9, 129.7, 129.3, 128.4,
127.2, 125.8. 122.0, 121.1, 83.5, 74.2, 53.8, 53.3, 40.5, 33.1, 28.3.
28.0, 23.5, 21.5; HRMS calcd for C32H39BrN3O3Na [M + HJ
592.21693, found 592.21666.
N-(BrPhF)alaninyllysine (16). The BrPhF-protected dipeptide
11(40 mg, 0.058 mmol) vas dissolved in 300pL ofCH2C12, treated
with C13CCO2H (236 mg, 1.44 mmol), and stirred for 72 h. The
mixture was diluted with 5 mL ofCH2C12, washed with 0.1 N HC1(2 x 3 mL). lyophilized, triturated with Et20, and purified on
reversed-phase preparative HPLC to afford 16 (22.6 mg, 73% yield)
as a white gum: [Œ]20D —3.1 (c 1.1, CH3OH); ‘H NMR (D20) ô
7.78 (U, J 7.5 Hz, 1H), 7.66 (U, J = 7.4 Hz, 1H), 7.47 (t, J 7.2
Hz, 1H), 7.32 (m, 3H) 7.21 (d, J = 8.5 Hz, 2H), 7.12 (m, 2H),
6.98 (d,J 8.6 Hz, 2H), 3.47 (t,J 6.6 Hz, 1H), 3.12 (q,J 6.6
Hz, 1H), 2.87 (m, 2H), 1.51 (in, 2H), 1.33 (m, 2H), 1.19 (d, J
7.1 Hz, 3H), 1.01 (m, 2H);’3C NMR (1320)6 175.5, 170.1, 140.8,
140.3, 140.1, 131.6, 130.8, 130.6, 129.0, 127.9, 126.9, 126.8, 124.9,
122.0, 120.9, 120.4, 73.3, 53.2, 52.7, 38.6, 29.5, 26.0, 21.6, 16.9;
HRMS calcd for C25H3,3rN3O3 [M + HJ 536.15433, found
536.15304.
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RÉSUMÉ
Des stratégies de synthèse de mimes peptidiques de tour 3 ont été développées
dans le but d’obtenir des dipeptides macrocycliques et bicycliques. Les dipeptides
macrocycliques ont été synthétisés à partir de dipeptide comportant des chaînes
latérales oléfiniques qui ont servies dans une réaction de fermeture de cycle par
métathèse. Ainsi, des dipeptides macrocycliqties de 8, 9, et 10 membres ont pu être
obtenus.
Ces derniers mimes macrocyclciques ont par la suite servi de précurseurs pour
obtenir de mimes dipeptidiques bicycliques. En effet ces macrocycliques ont pu être
traités dans une réaction de cyclisation transannulaire électrophilique. L’iode ainsi
que le bromure de phénylselenium ont pu être utilisés comme source d’électrophile
pour doiwer des acides aminés bicycliques de type [6.5.0j et [7.5.01.
Aussi, un nouveau groupement protecteur d’amines de type «safety-catch» a
été développé. Le groupement 9-(4-bromophényl)-9-fluorényl possède les mêmes
caractéristiques que son cousin, le 9-phényl-fluorényl, et en plus de pouvoir être clivé
en conditions douces avec une séquence impliquant un couplage d’amine catalysé par
le palladium et une hydrolyse en condition faiblement acidique.
Finalment des résultats préliminaires concemant l’application de la synthèse
de mimes peptidiques macrocycliques et bicycliques sur support solide sont
rapportés. Ces résultats pourront former la base d’un futur projet penneffant de
d’introduire des mimes peptidiques directement lors de la synthèse d’tin peptide sur
support solide sans avoir à synthétiser au préalable en solution le mime à être inséré.
11
MOTS CLÉS
Mimes de tours 13 macrocycliques, fermeture de cycle par métathèse d’oléfine, mimes
de tours B bicycliques, cyclisation électrophilique transannulaire, iodolactamisation,
synthèse peptidique stir support solide, résine de Wang, balyage conformationnet de
peptides. groupes protecteurs, 9-(4-bromophényl)-9-fluorényl. orthogonalité.
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ABSTRACT
Strategies for the synthesis of F3 turn peptide rnimetics have been developed to
obtain macrocv clic and bicyclic dipeptides. The macrocyclic dipeptides were
synthesized from dipeptides beanng olefinic side chains which were used in a ring
closing metathesis. This strategy lias Ied to the synthesis of macrocyclic dipeptides of
8-, 9-, and 10-mernbered rings.
Those macrocyclic rnirnetics tvhere also used as precursors for the synthesis of
bicyclic dipeptides. Effectively. these inacrocycles were treated in an electrophulic
transannular cyclization. Iodine and phenylselenium bromide were usèd as
electrophiles to yield the [6.5.0]- and [7.5.0]-bicydhc amino acids.
Also. a new amine safetv-catch protecting group was developed. The
protecting group, the 9-(4-bromophenyl)-9-fluorényl, possesses the same
charactenstics as its close cousin, the 9-phenyl-9-fluorenyl group, and eau be cleaved
under mild conditions after a hvo-steps process involving a palladiurn-catalyzed
cross-couphng of an amine followed by a rnild acid hydrolysis.
Finally, preliminaiy results were disclosed for the future synthesis of
macrocyclic and bicyclic peptidomimetics on solid phase. These restilts eau be the
basis of a future project allowing the svnthesis of peptidornimetics directly on the
growing peptide chain in a synthesis on solid support without having to synthesize the
peptidornimetics in solution prior to inserting it in the peptide.
iv
KEY WORDS
Macrocyclic J-tuni mimics, olefrn ring closing metathesis. bicyclic 13-turn rnimics,
electrophilic transannular cyclization, iodolactarnization, solid support peptide
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Les peptides endogènes sont reconnus pour être des molécules très
importantes pour la communication intercellulaire dans plusieurs systèmes
biologiques.’ Parmi les peptides les plus connus, on retrouve bien sûr l’insuline
(un peptide de 51 aa) qui, entre autres, stimule la consommation dc glucose et la
synthèse de glycogène, l’oxytocine (un peptide de 9 aa, Cys-Tyr-Ile-Gln-Asn
Cys-Pro-Leu-Gly-NH2) qui induit les contractions utérines lors dc l’accouchement
et la vasopressine (un peptide de 9 aa, Cs-Tyr-Phe-Gln-Asn-C’s-Pro-Arg-Gly
NH2) qui sert de diurétique. Toutefois, les peptides endogènes souffrent de
plusieurs limitations, ce qui a restreint leur utilisation en tant que médicaments2
ils sont rapidement métabolisés lors de la protéolyse dans le tractus gastro
intestinal, dans le sang et dans différents tissus; ils sont difficilement transportés
du tractus gastro-intestinal vers le sang et du sang vers le cerveau; ils sont
rapidement excrétés par le foie et les reins.
Au cours des trente dernières années, beaucoup de recherche a été
effectuée dans le but d’améliorer la biodisponibilité des peptides afin d’obtenir des
composés qui pourraient devenir des médicaments. Ceci a amené le concept de
peptidomimétisme3 où un composé possède une structure différente d’un peptide
endogène, mais possède toujours la possibilité d’interagir avec un récepteur
spécifique. Le design d’un mime peptidique dans le but d’en obtenir un composé
biologiquement actif se doit de prendre compte de deux facteurs structurels:4
l’ajustement optimal de la conformation du mime avec le site actif et
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l’emplacement d’éléments structuraux (groupes fonctionnels, régions polaires et
hydrophobes) à des positions définies afin que des interactions se produisent. De
plus, le mime peptidique devrait contenir des éléments qui pourraient contribuer à
ralentir le métabolisme du composé.
Le design d’un mime peptidique peut donc se faire en modifiant quatre
domaines différents d’un peptide. Tout d’abord, les chaînes latérales des peptides
peuvent être modifiées. Le remplacement d’acides aminés naturels par des acides
aminés synthétiques peut permettre d’améliorer la vitesse à laquelle le peptide est
métabolisé dans le corps et peut aussi donner une meilleure activité biologique.
Une autre pratique courante consiste à modifier les chaînes latérales des peptides
en remplaçant les acides aminés de configuration L formant le peptide par des
acides aminés de configuration D afin de modifier la stéréochimie du squelette
peptidique. Une deuxième possibilité implique la modification du squelette du
peptide par des groupements isostériques (figure 1). Chaque acide aminé
constituant le peptide peut être divisé en trois portions pouvant être subtituées par
des groupements isostériques la portion NH, la portion CH et la portion CO. La
portion NH peut être remplacée par un atome d’oxygène ce qui a pour effet de
transformer une fonction amide en ester pour former un depsi peptide. La portion
NH peut aussi être remplacée par un atome de souffre pour former un thioester ou
par une unité cétométhylène. Quant à la portion CH, elle peut être remplacée par
un atome d’azote pour former un azapeptide. On peut aussi utiliser des acides
aminés comportant deux chaînes latérales ou remplacer le groupe CH par BH pour
former un borapeptide. Le groupement carbonyle peut être substitué par un
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n = 1 ou 2
HB(OH)F
-j P=O(OH) j—
Figure 1. Modifications fréquentes du squelette peptidique.4
boronique. Il peut aussi être réduit en méthylène pour donner plus de stabilité
métabolique.
En plus de faire des modifications sur les portions NH, CH et CO d’un
peptide, des extensions de la chaîne peptidique comme l’utilisation d’acides
aminés de type f3 ont été employée pour faire des mimes peptidiques. Aussi la
fonction amide a été modifié de plusieurs manières comme dans le cas d’un





Figure 2. Représentation d’une hélice Œ, de tours 13 de type I et de type II ainsi
que d’un tour y de type I.
Bien entendu, la modification du squelette peptidique peut aider à
combattre la dégradation du mime peptidique contre le métabolisme
physiologique, mais un mime dont le squelette a été modifiée en utilisant les
fonctions citées précédemment ne génère pas nécessairement la conformation
nécessaire pour qu’il y ait un bon contact entre le mime peptidique et le récepteur.
C’est pourquoi beaucoup d’efforts ont été consacrés à la synthèse de mimes
comportant des éléments induisant des conformations étant reconnues comme
étant importantes pour la reconnaissance entre un peptide et son récepteur, par
exemple, les hélices a, les tours 13 et les tours y (Figure 2). Dans le cas spécifique
des tours 13, les différents types de tour sont caractérisés par les angles dièdres et
N’ du second (i + 1) et troisième (i + 2) acide aminé formant le tour (Figure 3).
Une méthode qui a couramment utilisée pour induire des conformations est la
formation de pont entre différentes parties du peptide. Plus spécifiquement dans
























Angles de torsion caractéristiques d’un tour 13
Depuis presque trois décennies, les lactames dipeptidiques ont été utilisées
afin de contraindre les conformations des peptides. Bien entendu, le modèle le
plus connu est celui développé par Freidinger, mieux connu sous le nom de
lactames de Friedinger (Figure 4)•5 Ces lactames dipeptidiques, une fois insérées
dans des peptides, permettent de mimer des tours f3 de type II’. Par exemple, la
lactame 1 a été utilisée lors de la synthèse d’un mime peptidique de la
«luteinizing honnone—releasing hormone» (LH—RH), une hormone importante























bicycliques ont été utilisés pour mimer les différents
secondaire.
1.2 Les lactames dipeptidiques










LH—RH mime peptidique de la LH—RH (8,9 fois plus active)
Figure 5. Transformation de la LH—RH en mime peptidique en insérant une
y-lactame de Freidinger.
que les acides aminés tyrosine. glycine, leucine et arginine en position 5,6,7 et $
formaient un tour f3 de type II’ lorsque l’hormone se liait à son récepteur (Figure
5). En effet le remplacement de la glycine en position six par la D-alanine
augmentait l’activité thérapeutique tandis qu’un remplacement par la L-alanine
diminuait l’activité thérapeutique. De plus le remplacement de la leucine par la
N-(methyl)leucine a permis de conserver la même activité thérapeutique que le
peptide parent suggérant la présence d’un tour de type f3. Lorsque la glycine à la
position six et la leucine en position 7 ont été remplacées par une y-lactame, il a
été possible de confirmer que la LH—R}1 adopte un tour f3 de type II’ lorsqu’elle
se lie à son récepteur puisque ce mime peptidique a permis d’augmenter l’activité







Figure 6. Substance P représentant un tour f3 proposé ainsi qu’un mime de ta
substance P incorporant une lactame dipeptidique de 10 membres.
Plus récemment, des lactames dipeptidiques macrocycliques ont été
synthétisées aussi dans le but de mimer des tours f3 (Figure 6). En 199$, un
dipeptide macrocyclique insaturé de 10 membres a été synthétisé afin de produire
un mime de subtance P (Arg—Pro—Lys—Pro—Gln—Gln—Phe—Phe—Gly—Leu
Met—NH2), un undecapepflde qui est impliqué dans la transmission de la douleur,
dans les constrictions brachiales et dans la vasodilatation.7 Des études
cristallographiques ainsi que des études par RMN ont permis de démontrer que le
dipeptide permettait de mimer le tour f3 de type I. Toutefois, lorsque ce modèle
fut inséré pour remplacer la glycine en position 9 et la teucine en position 10,
aucune activité thérapeutique n’a été observée, ce qui pouffait indiquer que la
substance P n’adopte pas de tour f3 de type I à cette position lorsqu’elle se lie à
son récepteur.
Plus dernièrement, des dipeptides macrocycliques de $ membres ont été
utilisés dans l’élaboration de mimes peptidiques (Figure 7). Deux différents
groupes ont entrepris de synthétiser les composés 4-8 qui pourraient mimer le
modèle Cys—Cys oxidé retrouvé entre autres dans le domaine extracellulaire N-
oS
N H2
Mime peptidique de la substance P
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Figure 7. Structures des différentes lactames dipeptidiques dc 8 membres
synthétisées.
terminal de la plupart des récepteurs acétylcholine nicotinique.8 Des études
computatioimelles préliminaires avaient relevé des différences importantes reliées
à la stéréochimic des deux composés.9 En effet des calculs de mécanique
moléculaire effectués dans les différents champs de force MM3 et AN{BER ont
montré le composé (3R,8R)-4 dans une conformation étendue. Toutefois, les
champs de force MM2, MM3 et AMBER ont tous montré une distance inférieure
à 7Â entre les carbones Œ en position 1 et 4 du composé (33.$R)-4. ce qui semblait
montrer la présence d’un tour f3. Lorsque synthétisé, les analyses
cristallographiques ont montré une diménsation du composé (3R,8R)-4 où deux
conformations étendues ont pu être observées.’0 Son énantiomêre, le composé
(38,85)-4, a aussi montré une conformation étendue qui mimait avec beaucoup de
précision le dipeptide Cys—Cys oxydé.1’ Une fois synthétisé, le dipeptide
(3R,$S)-4 a aussi montré l’exactitude des calculs effectués.9’1’ En effet, la
structure obtenue par diffractions de rayons X ainsi que les différentes expériences
RMN ont montré que le composé (35’.$R)-4 adoptait une conformation typique
d’un tour f3 de type VIb. L’introduction dune insaturation à l’intérieur de la






Figure 8. Représentation d’une lactame dipeptidique dc 9 membres.
5 adopte toujours une conformation étendue, le composé 6 est quelque peu
différent du composé (38,$R)-4 et mime un tour f3 de type VIa plutôt qu’un tour f3
de type VIb.
Quelques travaux ont aussi été effectués sur des lactames macrocycliques
de 9 membres (figure 8)12 La synthèse du composé 7 a permis d’entreprendre
des études RMN qui ont montré que le dipeptide adoptait une conformation qui
mimait un tour f3 de type II’.
En plus de pouvoir servir comme mimes de tour f3, les peptides
comprenant des cycles de plus grande taille ont montré leur utilité comme mimes
de brins f3.’3 En effet, la condensation de deux chaînes latérales pour former des
chaînons de 14 à 1$ membres semblerait empêcher la formation intramoléculaire
de pont hydrogène. Ainsi cette cyclisation permet de garder le mime peptidiquc
dans sa forme étendue pour se fixer au récepteur de diverses protéases. En
utilisant cette stratégie, plusieurs puissants inhibiteurs de la protéase du VIH ont
pu être synthétisés.’4
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1.3 Les dipeptides bicycliques
Autres l’utilisation de lactames dipeptidiques, l’incorporation d’un peptide
à l’intérieur d’une structure bicyclique a permis de restreindre la rotation des liens
qui forment les angles dièdres p et i. Il y a plus de vingt ans, le dipeptide 8,
connu sous l’acronyme BTD (Bicyclic Tumed Dipeptide), a été indroduit comme
mime de tour f3 de type II’ (Figure 9)13 Ce dipeptide a été introduit dans plusieurs
peptides’4 dans le but de forcer ces derniers à adopter un tour de type f3. Par
exemple, la séquence Arg—Gly—Asp (RGD) est contenue dans plusieurs peptides
comme la fibronectine, la vitronectine, l’osteopontine, les collagènes, la
thrombospondine et la fibrinogène. L’introduction du BTD dans un decapeptide
cyclique contenant cette séquence RGD a permis de mettre au point un mime
peptidique se liant sélectivement au récepteur ŒVf33.’5
Le succès de l’incorporation du BTD dans les peptides a mené vers de
nouveaux types d’acides aminés azabicylciques dépourvus d’hétéroatomes dans le
squelette régidifiant le dipeptide. Ces acides aminés azabicyliques sont reconnus
pour être plus stables face au métabolisme du corps humain que le BlD. La
synthèse d’acides aminés azabicycliques a d’ailleurs fait l’objet de plusieurs
revues16 et constitue un sujet de pointe de chimie organique. De plus en plus
H2N
figure 9. Structure du « Bicyclic Tumed Dipeptide» (BlD).
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d’efforts sont maintenant consacrés à l’obtention des acides aminés
azabicycliques portant des chaînes latérales qui permettraient de mimer avec plus
de précision la chaîne latérale des acides aminés endogènes. Ces mimes
peptidiques ont fait letir preuve en améliorant l’activité thérapeutique de certains
peptides lorsqu’ils ont été insérés dans divers peptides.
Par exemple, une librairie de pseudopentapeptides cycliques contenant les
acides aminés Arg-Gly-Asp (RGD) et différents azabicycles a été synthétisée dans
le but d’obtenir des inhibiteurs du récepteur Œvf33.17 Le récepteur Œvf33 est connu
pour être exprimé à la surface d’une variété de cellules et pour être impliqué dans
plusieurs processus pathologiques comme l’angiogenèse, l’ostéoporose et la
métastase tumorale. Ainsi les dipeptides azabicycliques 9-16 ont été synthétisés’8
et utilisés dans une synthèse peptidique sur support solide pour obtenir les
pseudopentapeptides qui ont été examinés lors de tests in vitro pour leurs habilités
à se lier au récepteur af33 purifié par rapport à la ‘251-echistatine (figure 10).
Ainsi, l’incorporation des dipeptides 12 et 16 a permis d’obtenir des inhibiteurs
donnant une valeur d’1C50 de 14.3 et 3.7 nM respectivement.
Plus nouvellement, une petite chimioffièque de tripeptides a été mise au
point dans le but d’obtenir des mimes du second activateur de la caspase dérivé de
la mitochondrie (second ,nitochondria-drived activator of caspas, Smac).’9 Cette
protéine est associée à l’apoptose dans les cellules. Certains petits peptides
mimant son activité ont montré irne hausse de l’activité anti-cancéreuse de













figure 10. Incorporation de différents dipeptides azabicycliques dans la
synthèse d’inhibiteurs du récepteur uv133.
différents azabicycles 17-19 ont été examinés comme peptide mimant la protéine
Smac. Le bicycle 7-5 19 a été identifié comme ligand avec un K de 150 1iM avec
le XIAP BIR3 (XIAP = X-linked inhibitors of apoptosis protein, BIR3 = third
baculovims inhibitors of apoptosis reapeat) (Figure 11). L’optimisation du
composé 19 a mené vers le tripeptide 20 et finalement au peptide 21 avec un K
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dc 0.025 j.tM. De plus, la stéréospécificité du composé 21 a pu être confirmé par





Figure 11. Tnpeptides synthétisés comme mimes du Smac.
1.4 Notre approche
Les deux sections précédentes ont fait mention de l’importance et de
l’utilité de l’emploi des dipeptides macrocycliques et bicycliques en
peptidomimétisme. Une méthode rapide et efficace permettant la synthèse de ces
deux types de mimes peptidiques serait donc d’une grande utilité. Nous avons
donc pensé à développer une stratégie qui permettrait d’obtenir rapidement et
efficacement soit un lactame dipeptidique, soit un dipeptide azabicyclique. Notre
stratégie implique donc le couplage dc deux acides aminés comportant des
chaînes latérales avec des oléfines terminales (Schéma 1). Ces deux oléfines
18
Chapitre 1 15
ii j] Couplage D
+
peptidique )m




n = 1 or 2




P = Groupe protecteur m 1 or 2
n 1or2








O CO2H O COMe
Schéma 1. Stratégie générale de synthèse de mimes dipeptidiques
macrocycliques et bicycliques.
pourront par la suite réagir dans une réaction de fermeture de cycle par métathèse
d’oléfines (RCM)2° pour former une lactame de 8, 9 ou 10 membres tout
dépendant de la longueur des deux chaînes latérales des acides aminés utilisés lors
du couplage. Le mime peptidique obtenu pourrait par la suite être transformé en
mime bicyclique via une réaction de cyclisation transannulaire qui serait induite
par la présence d’un électrophile. Ce dernier aurait pour rôle d’activer la liaision
double du macrocycle obtenu. De plus, l’utilisation d’électrophile comme l’iode,
les dérivés du sélénium ainsi que du mercure permettrait par la suite de
fonctionnaliser l’acide aminé azabicyclique obtenu afin de mieux mimer les
chaînes latérales des peptides.
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Cette stratégie s’illustre par sa simplicité. En effet, autre que l’étape du
couplage peptidique requis lors dc toute synthèse dc peptide, une seule réaction de
RCM nous sépare du mime macrocyclique tandis qu’une réaction dc RCM et une
cyclisation transannulaire nous sépare du mime bicyclique. Il est donc réaliste de
penser que cette stratégie de synthèse pourrait être adaptée à une synthèse sur
support solide qui est généralement utilisée pour la synthèse de peptides. Le
passage de la synthèse en solution vers la synthèse sur support solide permettrait
entre autres de faire un balayage complet d’un peptide en remplaçant chaque duo
d’acides aminés possible par soit un mime dipeptidique macrocyclique ou par un
mime dipeptidique azabicyclique afin d’obtenir plus d’informations sur la
conformation qu’adopte le peptide lors qu’il se lie à son récepteur.
1.5 Les groupes protecteurs
Bien entendu, toute synthèse multi-étapes effectuée doit tenir compte dc la
réactivité dc tous les groupements fonctionnels présents sur la molécule à être
transformée. Afin d’éviter certaines réactions secondaires, les groupements
protecteurs ont été utilisés afin de transformer certaines fonctions réactives en
fonctions moins réactives, donc moins susceptibles de réagir. L’utilisation d’un
groupe protecteur, même si elle nécessite généralement l’ajout de deux étapes
(soit la protection et la déprotection), est donc essentielle lors de la synthèse de
dipeptides macrocycliques et bicycliques comportant plusieurs groupements





figure 12. Élaboration du groupement 9-(4-bromophényl)-9-fluorénvl comme
groupement protecteur « safety-catch ».
Tout au long du développement de notre approche sur la synthèse de
mimes peptidiques macrocyliques et bicycliques, un nouveau type de groupe
protecteur a été mis au point. Cette dernière stratégie de protection a été inspirée
par le groupement 9-phényl-9-fluorényl, largement utilisé pour la protection
d’amines (figure 12). Ce groupement à, entre autres, la propriété d’être stable en
condition modérément acides, mais surtout de protéger la configuration
stéréochimique du centre u d’un acide aminé.2’ Le groupement 9-(4-
bromophényl)-9-fluorényl a donc été mis au point comme groupement protecteur
« safety-catch» pouvant être clivé dans des conditions acides plus douces lors
d’un couplage croisé d’une amine catalysé par Le palladium, suivi d’une solvoLyse.
Les groupements protecteurs « safetv-catch» sont des groupements reconnus pour
être stabLes par rapport à une panoplie de conditions réactionnelles, mais
facilement clivables lorsqu’on décide de les activer. Un bon exemple de
groupement protecteur « safety-catch» est l’utilisation d’une phénylsulfonamide
pour prévenir toute réaction sur un groupement carbonyle (Schéma 2)22 Le
groupement N-acyl sulfonamide est stable sous des conditions acides et basiques
pennettant de modifier le reste de la molécule sans avoir à ce soucier du
groupement acvle. Lorsque désiré, le groupement sulfonamide peut être clivé en
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Ph--NH
CH2N2 Ph-g-N” NucIéophiIe Ph--NHMe +
R Nu
Stable sous conditionns Activation Facilement clivablebasiques etacidiques perdes nucleophiles
Schéma 2. Utilisation du groupement phénylsulfonamidc comme groupement
protecteur « safety-catch ».
l’activant avec le diazométhane et en le déplaçant avec un nucléophile comme une
amine ou un ion hydroxyde.
En conclusion, le present mémoire élaborera sur des nouvelles méthodes
de synthèse de mimes peptidiques, plus spécialement dans le cadre de synthèse de
dipeptides macrocycliques et dipeptides bicycliques. Le point fort de cette
méthodologie est la conversion directe d’un mime macrocyclique en mime
bicyclique. De plus, la conception d’un nouveau groupe protecteur de type
«safety-catch» pouvant être clivé dans des conditions douces, lorsque désiré.
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2.1 Note
Ce chapitre provient de la fusion entre un article publié dans le Journal of Organic
C’hemistrv ainsi que les corrections et additions qui ont été publiées dans le même
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Figure 13 Graphical Abstract
A systernatic smdy vas performed to establish general synthesis protocols for
fonning enantiomerically pure macrocyclic dipeptide lactams. Focusing on
macrocycles of $-, 9-, and 1O-mernbered rings, effective syntheses were achieved by
a sequence featuring peptide coupling of allyl- and homoallyl-glycine building bïocks
followed by nng-closing metathesis. The 8-membered lactam possessing cis-ainide
and cis-olefin geometiy as well as 9-membered lactams having trans-amide and cis
olefin configurations were effectively prepared by a general strategy employing the
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respective protected dipeptide, the first generation of Gmbbs’ catalyst, and temporaiy
protection of the central amide as a benzyl derivative. The 1 O-mernbered macrocycle
was synthesized possesing cis- or trans-olefin geornetry by employing similar
metathesis conditions in the presence or absence of ternporaiy benzyl amide
protection, respectively.
2.3 Introduction
13-Turns in peptides and proteins are of interest because of their structure and
biological activity.’ Polar in nature, these secondary structures generally occupy the
surfaces ofprotein molectiles, where they are involved in recognition and binding.2 B
tums have also been shown to be important for receptor affinity in biologically active
peptides, such as somatostatin,3 MSH,4 bradykinin,5 and LHRH.6 Mirnics of B-tums
are thus desirable tools for studying the stnicture-activity relationships responsible for
protein and peptide biology.7
Strategies to design B-tum mimics have often constrained the peptide
backbone dihedral angles. For example, fused bicyclic systems, such as
azabicyclo[X,Y,Olalkanone arnino acids 23-26, of valying ring sizes have been used
as rigid dipeptide surrogates7 that stnicturally constrain three contiguous dihedral
angles, p, ii,i, and cù, of a B-turn segment within the body of the heterocycle (figure









































favor type II and II’ B-turns8’9 contingent on their stereochemisùy, as evident from
X-ray diffractometiy, IR, and NMR spectroscopy as well as theoretical calculations.1°
Because differences in the type II turn dihedral angle have been observed after
variation of the ring sizes in these bicyclic mimics. application of sets of related
azabicycloalkane amino acids has thus proven effective for studying the effect of turn
geoinetly on the biological activity of native peptides.”2
Alternative scaffolds are needed to cover a wider range of tum geometnes in
order to befter mimic natural diversity and to enhance success in peptide mimicry.
Macrocyclic dipeptide lactmiis of 8-, 9-, and lO-members have been less well
investigated relative to their bicyclic cousins, in part due to the difficulties inherent in
synthesizing such medium-sized ring systems.13
The syntheses of eight-mernbered macrocycles, such as 27, have been
accomplished by ring-closing metathesis. Consfrained dipeptide ($,R)-27 (R = Ac, X
NHMe) was shown to adopt a conformation similar to that of an ideal type VIa B
tum, as demonstrated by NMR spectroscopy and X-ray analysis.14 Although the type
VI -tum did not possess proline, the eight-membered macrocycle forced the amide
between the i + 1 and i + 2 residues to adopt the cis-isomer geometiy, as illustrated by
X-ray structural analysis, which also revealed a cis-olefin in a folded boat-boat
conformation.14 The saturated analogue of 8-membered lactam ($,R)-27 was also
shown to adopt a cis-arnide type VIb 13-turn conformation by NMR, computational,
and X-ray analyses.14 Their cis-amide geometiy and their propensity to favor type VI
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13-tunis rnakes eight-membered lactams (27) stmcturally comparable to other type VI
B-tum mimics, such as 5-tert-butviproline-containing peptides.’7
Among the few svntheses of nine-rnernbered macrocyle dipeptide lactams, an
Ugi-multicomponent reaction followed by nng-closing metathesis has been used to
prepare unsaturated nine-rnembered lactani 2$ (Ri = CH3CO, R2 PhCH2, X =
OEt), albeit as a racemic isornenc mixttire.18 These nine-membered macrocycies were
shown to possess cis-olefin and trans-amide geometry by NMR analysis. The (8,5)-
isorner of 28 (R1 = Bn, R2 = COCH2NHBoc, X = OEt) was shown to adopt a type II’
B-tum by computational analysis and NMR spectroscopy.
The iO-rnembered macrocycle dipeptide lactam (31, R = Boc. X = OMe) lias
also been svnthesized by ring-closing metathesis and shown to possess a trans-olefm
geometiy and p, p. and o torsional angles similar to that of an ideal type I 13-tum, as
demonsfrated by X-ray and NMR analyses.19
With the precedent that 8-, 9-, atid 1 O-membered macrocyclic peptide lactams
adopted respectively type VI, II’, and 1 13-tums, respectiveiy, we souglit to develop a
general means for constmcting the set of heterocyclic dipeptides 27 and 29-31 (R =
Boc or fmoc. X = OH). We envisioned that this set will serve in studies of
biologically active peptides as wetl as intermediates for trans-annular cvclizatioris to
prepare azabicvcloX.Y,O]alkanone amino acids related to 23-26.
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Medium-sized macrocyclic lactams of 8-, 9-, and 10- members have been
fraditionally harder to forrn than their srnaller and larger-sized counterparts;13
however, ring-closing metathesis has significantly advanced their synthesis. For
example, N-alkyl lactams of 6-10 members have been prepared by RCM.2° Transient
N-alkylation of the central amide with a 2,4-dimethoxy benzyl group (Drnb) was also
shown to be essential to favor a cis-amide geornetry and facilitate metathesis in the
synthesis of eight-mernbered lactams (5)•1415 Moreover, RCM has been used
effectively to make larger ring systems that have constrained peptide confonnations.2’
Considenng these resuits and the need for material on a suitable scale and in a
protected form for peptide synthesis, we undertook a detailed study to prepare
macrocydlic dipeptide lactams of s-10 members by a general strategy featuring RCM
(Scheme 3).
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Scheme 3. General Scheme for the Synthesis ofMacrocyctic Dipeptides
2.4 Results anci Discussion
2.4.1 Dipeptide Precursor Synthesis. hie construction of s-, 9-, and 10-
rnembered ring sizes necessitated the synthesis and coupling of allylglycine and
hornoaliviglycine units pnor to RCM. Allylglycine had been synthesized by a variety
of rnethods;22 however, our expertise with Œ-tert-butyl N-(PhF)aspartate 3-aldehyde
(32, Plif = 9-phenylfluren-9-yl)23 served as motivation to employ this chiral educt in
the synthesis of allylglycine (Scheme 4). Aldehyde 32 vas synthesized on a 7-g scale
from aspartic acid231’24 in five steps and 47% overatl vield. N-(Phf)AllylgÏycine ter!
butyl ester 33 was obtained in 95% yield from the Wittig reaction of aldehyde 32 and

















HCI•H2N CO2Me FmocHN CO2H
36 35b
Scheme 4 Synthesis ofAllylglycine Components 35 and 36
KHMDS in THF.25 Allylglycine hydrochioride 34 was quantitatively prepared from
the treatment of 33 with TFA, which cleaved both the tert-butyl ester and PhF grotips,
foliowed by conversion of the trilluoroacetate sait to the hydrochioride using aq HC1
and iyophilization. N-(Boc)- and N-(Fmoc)allylglycines 35a and 35b were then
prepared by the protection of 34 with (Boc)2O26 and FmocOSu,26b respectively,
under basic conditions. Allylglycine methyl ester hydrochioride 36 was quantitatively
obtained by the treatment of 34 with methanol and thionyi chloride. The higher N
(Boc)- and N-(Frnoc)-protected homologues homoaily1giycines 38a and 38b) were
synthesized respectively in five steps from serine using reported procedures (Scherne
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5)27 Briefly, serine vas converted to iLs methyl ester hydrochioride, which was
protected using Boc2O or FmocOSu and transformed to N-(Boc)- or N
(Fmoc)iodoalanine methyl ester using iodine, PPh3, and imidazole.28 11e iodide was
then converted to a zincate and coupled to allyl chlonde using CuBrDMS. N
(Boc)amino ester 37a was hydrolyzed with LiOH and deprotected with 50% TFA in
CH2C12 to provide N-(Boc)homoallylglycine 38a and homoallylglycme methyl ester
tnlluoroacetate 39, respectively, as components for peptide coupling. N
(Fmoc)Homoallylglycine 38b was obtained by hydrolysis of N-(Fmoc)amino ester
2937b using 0.8 M calcium chlonde and 0.5 M sodium hydroxide m iPrOH/H20 (7:3).
OH Ref27
H2NCO2H RHN CO2Me
37a R = Boc
37b R = Fmoc
50% TFNCH2CI2
/ LIOH, Dioxane/H20 or
CaCI2, NaOH, i-PrOH/H20
TFA•H2N CQ2Me RHN CO2H
38aRBoc (97%)
38b R = Fmoc (95%)
Scheme 5. Synthesis ofHomoallylglycine Components 38 and 39
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Considenng that rotation around the amide bound would influence the rate of
RCM of the dipeptides, we synthesized an array of secondaiv benzyl amino esters to
prepare tertiaiy amides having a lower barrier for isornenzation about the amide bond
(Scherne 6). This hypothesis was supported by earlier studies of the synthesis of
eight-membered lactams that dernonstrated the utility of the acid labile 2,4-
dimethoxybenzyl cDmb) group in the RCM step.15 The related 2-hydroxy-4-
methoxybenzyl (Hmb) group has been ttsed to sunnount difficult couplings in solid
phase peptide synthesis,3° and we envisioned that secondaiy amino esters bearing this
group could have better reactivity than their Drnb cousins. Similary, the 2-hydroxy-6-
nitrobenzyl (Hnb) group was considered as a photocleavable protection reported to
favor coupling by O to N acyl transfer in a similar way as the l-1mb auxiliaiy.31
Reductive aminations of imine prepared with the respective benzaldehyde and allyl
and homoallylglycine methyl esters (36 and 39) were perfonned using NaBH(OAc)3
to fumish Drnb-, l-1mb-, and Hnb-protected arnino esters 40 and 41 in yields vwying




X H3N CO2Me 2.RCHO, DCM N CO2Me
36 m = 1, x =
NaBH(OAc)3 H
39 m2,X CF3C02 40a m=1, RDmb(74%)
40m = 1, R Hnb (52%)
41a m = 2, R = Dmb (70%)





Scherne 6. Synthesis ofN-Benzyl Components 40 and 41
2.4.2 Coupling of the Fragments. The set of dipeptides 43a-45a was assembled first
by combining allylglycine and homoallylglycine methyl ester saits 36 and 39 as
amine components and N-(Boc)allyl- and N-(Boc)homoallylglycines 35a and 38a as
acid components using TBTU as tue coupling agent in $5-87% yields (Table 1).
Coupling of the Dmb secondary amino esters proved more difficult, and many
coupling conditions were tried;32 however, only HATU as the coupling agent with N
ethylmorpholine as the base was found to be effective for making N-Boc-protected
dipeptides 42b-45b bearing a 2,4-dimethoxybenzyl tertiaiy amide bond in yields
valying between 71% and 86%. Changing from Boc protection to Fmoc did flot affect
coupling, and dipeptides 43c and 44c were obtained in 85% and 82% yields,
respectively. The use of HATU could be avoided by employing N




PHN CO2H HN CO2Me PHN”_N CO2Me
R O R
Acid m P Amine R Conditions Amide Yield (%)
35a 1 Boc 40a 1 Dmb A 42b 71
35a 1 Boc 39 2 H B 43a 86
35a 1 Boc 41a 2 Dmb A 43b 86
35b 1 Fmoc 41a 2 Dmb A 43c 85
38a 2 Boc 36 1 H B 44a 85
38a 2 Boc 40a I Dmb A 44b 81
3$b 2 Fmoc 40a 1 Dmb A 44c 82
38a 2 Boc 40b 1 Hnb C 44d 87
38a 2 Boc 39 2 H B 45a 87
3$a 2 Boc 41a 2 Dmb A 45b 74
38a 2 Boc 41b 2 Hmb C 45c 86
Table 1. Dipeptide Assembly a Condition A: HATU, N-Ethylrnorpholine, CH2C12,
il; condition B: TBTU, DIEA, CH2C12. rt; condition C: symmetric anhydride,
benzylic amino ester, CH2C12, rt.
from N-(Boc)homoallylglycine 38a, respectively, in situ to furnish 45c in 86%
yields. Atternpts to apply the symmetrical anhydride conditions using N
(Hnb)allylglycine 40b gave 44d in 87% yield; however, this route was flot pursued
further because of the difficulties in making tue requisite 2-hydroxy-6-
nitrobenzaldhyde.33
2.4.3 Ring-Closing Metathesis. The importance of the rate of amide bond
isomerization on the ring-closing metathesis was realized in the synthesis of nine
rnembered macrocyles, which could not be formed without a tertiaiy amide. When
cyclization by olefin metathesis was examined on dipeptides bearing no benzyl group
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at the amide nitrogen, secondai-y amides 43a and 44a failed to cyclize using both the
first and second generation Grubbs’ catalyst in a variety of solvents at reflux and
room temperature. Dipeptide 43a also did not cyclize to a nine-mernbered ring in the
presence of Ti(O-iPr)4, which has been used previously to prevent the formation of a
cyclic chelate behveen the catalyst and an amide.34 As reported,19 10-membered
macrocyclic dipeptide 49a vas fomied on cyclization of dipeptide 45a using the first
generation of Grubbs’ catalyst at high dilution (0.7 mM).
Macrocycles of eight and fine members were synthesized from dipeptides
bearing only a benzyl group on the nitrogen of the amide. Dmb-analogues 42b, 43b
and c, 44b and c. and 45b reacted with the first generation Gnibbs’ catalyst to provide
8-10 membered macrocycles 46a, 47b and c, 48b and c, and 49b, respectively, in 71-
81% yields (Table 2). The 10-membered macrocycle (49b) was fonned in 87% yield
from tertiaiy amide 45b employing die sanie conditions used to cyclize secondaiy
amide 45a at a concentration four and a half times higher; however. the olefin
geometiy was shown to be cis as discttssed below. The phenol of the I-1mb group was
also tolerated by the catalyst, and 10-mernbered macrocyle 49c was prepared in 86%
yield. The tertiary amide facilitated amide bond rotation and favored conformers in
which the ring-closing metathesis was possible. In die smaller-ring cases, without the
benzyl group, the cis-amide isomer was disfavored energetically, and the barner for
isomenzation was higher such that macrocylization was inhibited.
Chapifre2 36
PCy3
[I J 20 moI
)m ([1 PCy3 ( m )n
PHN’_N”CO2Me CH2CI2, reflux PHN N CO2Me
O R O R
Amide P m n R Macrocycle EIZ Yield (%)
42b Boc 1 1 Dmb 46a Z 78
43a Boc 1 2 H 47a - 0
43b Boc 1 2 Dmb 47b Z 80
43c Fmoc 1 2 Dmb 47c Z 75
44a Boc 2 1 H 48a - O
44b Boc 2 1 Dmb 48b Z 81
Fmoc 2 1 Dmb 48c Z 71
45a Boc 2 2 H 49a E 77
45b Boc 2 2 0mb 49b Z 87
45c Boc 2 2 Hmb 49c Z 86
Table 2. Macrocycle Formation
The Dmb and Hmb groups were reported to be easily cleaved under acidic
conditions.30’35 However, N-Boc-protected-9- and 10-rnembered lactams 47b, 48b,
and 49b and c bearing Dmb and Hmb groups were recovered as deprotected amines
without the loss of the benzylic tertiaiy amide after prolonged treatment with 50%
TFA in CH2C12. Altematively, both the Boc and Dmb groups were rernoved upon
exposure of eight-rnembered lactam 46a to the same TFA in CH2C12 conditions as
reported.15 In contrast to the N-Boc-protected lactams, N-Frnoc-protected lactams 47c
and 4$c were quantitatively converted in 30 min to their secondaiy amide derivatives
50 and 51 by treatment with 50% TFA in CH2CI2 (Scherne 7). This behavior confinns
the hypothesis36 that difficulties in cleaving Drnb groups are due to the formation of a
neighboring positively charged ammonium ion upon deprotection of ffie Boc moiety,
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which inhibits protonation of the amide and shuts down the reaction. Conversion of
N-Boc-protected macrocycles 47b and 4$b to N-Fmoc-derivatives 47e and 4$c gave
average yields of 35-45%, illustrating an advantage in starting with N-Fmoc-protected
amino acids. Finally, esters 50 and 51 were hydrolyzed using 0.5 M NaOH and 0.8 M
CaC12 in iPrOHlwater (7:3) to obtain the protected amino acids (52 and 53) suitable




47b m 1, n 1




52m 1 n 1




47c m = 1 n = 1





50m = 1, n 1
51 m = 2, n = O
Scheme 7. Synthesis of Macrocycle N-(fmoc)-dipeptides 52 and 53 a Reagents and
conditions: (a) 50% TFA/CH2CI2; (b) FmocOSu, Na2CO3. acetone/H20; (e) 0.8 M
CaC12I 0.5 M NaOH, i-PrOHJH2O.
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The olefin geometry was determined based on the vicinal coupling constant of
the vinyl protons. In the case of eight-rnernbered lactam 8. 8)-27, a coupting-constant
value of 10.4 Hz vas obsen’ed and assigned to cis-olefm geornetiy. The vinyl protons
of the olefin m 9-rnembered lactams 47c and 53 tvere observed as quadntplets;
however, decoupling experiments by irradiation of the allylic signais at 2.70 and 2.30
pprn for 47c and at 2.69 ppm for 53 demonstrated that the vinylic coupiing constant
for both compounds was 10.5 Hz consistent with a cis-olefin. Sirnilarly, the vinyl
coupling constant of the olefin of 10-rnembered tertiaiy lactam 49b was 11.0 Hz,
indicative of a cis double bond. The X-ray structure of macrocycle 49a which was
prepared from linear precursor 45a bearing a secondan’ amide had previously
der;ionstrated the presence ofa trans-oiefin.19
The amide isomer geometry of 8- and 10-membered lactams 27 and 31 were
assigned cis and trans, respectively, based on analogv to literature compounds 2714
and 31,19 for which X-ray structures were obtained. The assignment of the amide
isomers of nine-membered lactams 52 and 53 was made based on 2D NMR
experiments. Initially, COSY spectra of 52 and 53 were performed in pyridine-d5 and
CDC13, respectiveiy, to assign the protons for each compound. Subseqtiently, NOESY
spectra were perfonned to measure long-distance transfers of magnetization. In the
NOESY spectrum of both 52 and 53, no transfer of inagnetization between the CH
protons was obsen’ed using a varietv of mixing times. Because an amide cis isomer
would be expected to exhibil strong NOE bctween the neighboring CcH protons, the
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lack of such a transfer of magnetization leads us to assign the amide trans isomer
geometiy for 52 and 53.
2.5 Conclusion
A general methodology has been developed for synthesizing enantiomencally
pure 8-, 9-, and 1O-rnembered niacrocyclic dipeptides. This methodology has
provided the first syntheses of nine-membered lactams 29 ami 30, as well as a more
practical route for making 1 O-membered lactam 31. The importance of transient N
aikylation of the central amide was demonsfrated to facilitate ring-closing metathesis,
such that higher concentrations (3.15 mM) could be used without evoking dimer or
polymer formation. As reported, the cis-olefin geometiy was found in eight
membered lactam 27. The 9-membered lactams 29 and 30 also possessed cis-olefin
geometry. On the other hand, olefin geometiy was contingent on the manner that 10-
membered lactams 49b and 49a were synthesized; tertiaiy amide 45b gave the cis
olefin and secondary amide 45a provided trans-olefin. The amide bond geometiy
was shown to be cis in the case of 27 and trans for macrocycles 29-31. A more
detailed investigation of the conformation of 29 and 30 in peptide analogues is
presently under study. In light of the ability of these constrained dipeptide surrogates
to adopt conformations similar to natural 3-tums, this practical methodology should
be ofgeneral utility for research in peptide science and medicinal chemistry.
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2.6 Experimental Section
tert-Butyl (2S)-2-j(N-(PhF)aminojpent-4-enoate (33). A ri solution of
rnethyltnphenylphosphoniurn bromide (13.2 g, 37 mmol) in THF (103 mL) was
treated with a 0.5 M solution of KHMDS in toluene (67 mL, 33 mmol), stirred for 30
mm, and treated dropwise with aldehyde 32 (7.64 g, 18.5 mmol, prepared according
to ref 23) in THF (103 mL) over 10 min. The reaction mixture vas stirred for 1 h,
quenched with 200 mL of a saturated solution of NH4C1, and the phases were
separated. The aqueous layer was extracted twice with 150 mL of Et20. The
combined organic layers were washed with brine, dried over MgSO4, filtered, and
concentrated. Chromatographv (7% EtOAc/hexanes) afforded allvlglvcine 33 (7.22 g,
95% yield) as a clear oil: [u]20D +163.7° (c 1.0. CHCI3), lit.37 [.]20D 168.7° (c 1.0,
CHC13). The ‘H and ‘3C NMR spectral data tvere consistent with the literaturc.37
(2S)-2-Aminopent-4-enoic acid hydrochloride (34). TFA (60 mL) was added
dropwise to a solution of allylglycine 33 (7.22 g, 17.5 inmol) in CH2C12 (60 mL).
Once the addition was completed, Et3SiH (7 mL, 43.8 mrnol) was added to the
solution, which was stirred for 15 h. The volatiles were evaporated, and the residue
was dissolved in 3:1 hexanes/Et20 (50 mL) and treated with 0.5 N HC1 (25 mL). The
phases were separated, and the organic layer was extracted twice with 0.5 N HC1. The
combined aqueous layers were lyophuized to give amino acid hydrocliloride 34 (2.50
g, 94% yield) as a white solid: mp 205-207°C; 1H NIvIR (CD3OD): 55.79 (in, 2H),
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5.29 (m, 2H), 4.06 (dd, 1H, J 7.1, 5.1 Hz), 2.6$ (m, 2H); ‘3C NMR (CD3OD):
ô169.4, 130.1, 119.7, 51.6,34.0. MS (ESI,rn/z): 116.0 (MH).
(2S)-2-j(tert-Butoxycarbony])amino]pent-4-enoic acid (35a). A 1:1 dioxane/H20
solution (33 mL) containing hydrochioride 34 (750 mg, 4.95 mmol) was treated with
NaOH (436 mg, 9.90 mrnol). After the NaOH dissolved, Boc2O (1.30 g, 5.94 mmol)
vas added to the mixture in three portions over 10 min. The mixture was stirred for
18h. The dioxane was removed by evaporation. The cnide mixture tvas diluted wiffi
F120 and acidified to pH 3-4 with a 10% KHSO4 solution. This aqueous solution was
extracted with Et20 (three times). The combined organic layers were washed with
brine, dried over MgSO4, filtered, and concentrated to give N-(Boc)allylglycine 35a
(1.03 g, 97% yield) as a thick clear oil: [z.120o +14.50 (c 1.28, CHC13); The ‘H and ‘3C
NMR were consistent with the literature.22c HRMS calcd for C10H,7NO4Na,
238.10498; found, 238.10538.
(2S)-2-j(9H-Fluoren-9-ylmethoxycarbonyl)amino]pent-4-enoic acid (35b). A 1 1
acetone/H20 solution (67 mL) containing hydrochioride 34 (1.5 g, 10 mmol) vas
treated with Na2CO3 (2.1 g, 20 mmol) and FmocO$u (3.3 g, 10 rnmol). The mixture
vas stirred for 18 h at room temperaflire and concentrated. The cmde mixture was
diluted with H20 and acidified to pH 3-4 with a 10% KHSO4 solution. This aqueous
solution was extracted with EtOAc (three times). The combined organic layers were
washed with brine. dried over MgSO4, filtered, and concentrated to give N
(Fmoc)allylglycine 35b (2.36 g, 70% yield): mp 134-135°C; [120o +10.6° (c 0.93,
CHC13); ‘H NMR (CD3OD): 7.6$ (d, 2H, J = 9.9), 7.59 (111, 2H), 7.32 (t, 2H, J =
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9.7), 7.23 (t, 2H, J 9.9), 5.64 (in, 1H), 5.09 (m, 3H), 4.25 (in, 2H), 4.12 (m. 2H),
2.57 (m, 1H), 2.44 (m, 1H); ‘3C NMR (CD3OD): M75.2, 158.5, 145.3, 145.1, 142.5,
134.7, 128.8, 128.1, 126.3, 120.8, 118.7, 68.0, 55.1, 37.1; HRMS calcd for
C20H19NO4Na, 360.12063; fotmd, 360.12080.
Methyl (2S)-2-aminopent-4-enoate hydrochloride (36). SOC12 (0.55 mL, 19.8
mmol) was added dropwise to a solution of allylglycine 34 (20g, 13.2 mmol) in
MeOH (22 mL) at 0°C. The mixture vas allowed to wann to room temperature,
stirred ovemight, and evaporated to give methyl ester 36 (2.16g, 99% yield) as a
white solid: mp 91-92°C; [:j20D +8.3° (c 1.07, CH3OH); ‘H NMR (CD3OD): 5.76
(in, 1H), 5.28 (m, 2H), 4.15 (dd, 1H, J = 6.8, 5.5), 3.83 (s, 3H), 2.69 (m, 2H); ‘3C
NMR (CD3OD): ô168.8, 130.1, 120.1, 52.1, 52.0, 34.1; HRMS (MH) calcd for
C6H11N02, 130.08626; found, 130.08636.
(2S)-2-j(tert-Butoxycarbonyl)aminoJhex-5-enoic acid (38a). A solution of N
(Boc)homoallylglycine methyl ester (37a, 400 mg, 1.64 rnmol prepared according to
ref 27) in 1:1 H20/dioxane (16 mL) was freated with LiOl+H20 (103 mg, 2.47
mmol), stirred for 3 h, and evaporated to a residue that was partitioned between H20
(20 mL) and EtOAc (20 mL). The aqueous phase was acidified with 0.1 M HC1 to pH
4 and extracted hvice with EtOAc (20 mL). The combined organic extracts were
washed with brine, dried over MgSO4, filtered, and concentrated to afford acid 38a
(0.364 g. 97% yield) as a colorless ou: fr:120D -1.1° (e 1.3 1. CH3OH); ‘H NMR (400
MHz. CD3OD): ô5.82 (m. 1H), 5.03 (in. 3H), 4.0$ (m, 1H). 2.15 (m, 2H). 1.88 (in.
1H), 1.73 (m. 1H), 1.44 (s, 9H); ‘3C NMR (75 MHz, CD3OD): ô175.2. 157.1. 137.4,
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115.0, 79.4, 53.2, 31.1, 30.0, 27.7; HRMS calcd for C11H19NO4Na, 252.12063; found,
252.12089.
General Procedure A: Reductive Aminations. Allylglycine methyl ester
hydrochioride 36 or homoallylglycine methyl ester trifluoroacetate 39 (3 mmol) was
treated with 20 mL of a saturated NaHCO3 solution and extracted with 3 x 25 mL of
CH2C12. The combined organic layers were washed with 20 mL of brine and dried
over MgSO4, filtered. and concentrated to a volume of 30 mL. The selected
benzaldehyde derivative (3.3 mmol) and NaBH(OAc)3 (4.5 mmol) were addedto the
mixture. which vas stirred for 18 h at room temperature, treated with 20 mL of
saturated NaHCO3, and stirred for 30 min. The aqueous layer was separated and
washed with 3 x 20 mL of CH2CI2. The combined organic layers were washed with
brine, dned over MgSO4, filtered, and concentrated to a residue that was punfied by
chrornatography.
Methyl (2S)-2-j(2,4-Dimethoxybenzyl)amin o]pent-4-enoate (40a).
Chromatography of the product from 36 (20 mmol) using 30:70 EtOAc/hexanes as
the eluant gave 40a as ayellow oïl (74%yield): 1HNMR: 57.10 (d, 1H,J 7.8), 6.39
(m, 2H), 5.69 (m, 1H), 5.08 (m, 2H), 3.81-3.64 (ni. 11H), 3.11 (t, 1H,J 6.6), 2.39
(t, 2H, J 6.5), 2.22 (bs, 1H); 13C NMR: c174.8, 160.0, 158.4, 133.6, 130.2, 120.0,
117.6, 103.5, 98.2, 60.0, 55.1, 55.0, 51.4, 46.8, 37.5. MS (EST, mlz): 280.1 (MH).
General Procedure B: Peptide Coupling using HATU. The selected N-protected
arnino acid (1.5 eqtiiv) and N-benzyl amino ester (1.0 equiv) were dissolved in
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CH2C12 (0.07 M), treated with N-ethylmorpholine (1.5 equiv) and HATU (1.5 equiv),
stirred for 24h, and diluted with water. The aqueous layer was extracted with CH2C12
(3 times). The combined organic layers were washed with bnne, dried over MgSO4,
flltered, and concentrated to a residue that vas punfied by chromatography.
N-(Fmoc)-L-AlIy]glycinyl-N-(2,4-dimethoxybenzyl)-L-h omoallylglycine methyl
ester (43c). Chromatography of the product from 35b (1.5 rnrnol) and 41a (1.0
mrnol) using 30:70 EtOAclhexanes as the eluant gave 43c (85% yield):1H NMR:
7.76 (U, 2H, J = 7.5), 7.62 (dd, 2H, J = 3.3, 3.4), 7.39 (t, 2H, J = 7.5), 7.30 (t, 2H, J
= 7.4), 7.07 (d, 1H,J= 8.0), 6.40 (dd, 2H,J=2.l, 2.3), 5.81-5.65 (m, 3H), 5.14 (m,
2H), 5.05 (in, 1H), 4.98 (in, 2H), 4.67 (d, 1H,J= 15.8), 4.46-4.29 (m, 3H), 4.24-4.22
(t, 1H, J= 7.1), 4.13 (m, 1H), 3.76 (s, 6H), 3.57 (s, 3H), 2.59 (ni, 1H), 2.45 (rn, 1H),
2.11 (m, 1H), 2.03 (m, 2H), 1.80 (m, 1H); 13C NMR: 171.6, 171.0, 160.9, 158.6,
155.3, 143.7, 141.1, 137.3, 132.3, 130.2, 127.5, 126.8, 125.0, 124.9, 119.8, 11$.7,
115.8, 115.4, 103.5, 98.3, 66.7, 57.7, 55.2, 55.0, 51.8, 50.7, 47.0, 37.8, 30.4, 28.1. MS
(ESI, mlz): 635.2 (MNa).
Genera] Procedure C: Ring-Closing Metathesis. In a flame dned flask, dipeptide
(1.0 equiv) was dissolved in diy CH2C12 (3 mM). The mixture was heated for 10 min
at 35 C, treated with bis(tricyclohexylphosphonium)benzvlidine ruthenitim (IV)
dichionde (RuC12(=CHPh)(PCy3)2, 20 mol %), heated at reflux for 72h, and
concentrated. The crude residue was punfied by chrornatography to afford the
unsaturated lactam.
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Methyl (E, 3S, 9S)-3-N-(Fmoc)amino-1-(2,4-dimethoxybenzyl)-2-oxo-2,3,4,5,8,9-
hexahydro-1H-Azonine-9-carboxylate (47c). Chrornatography of the product from
43c (0.4 mrnol) using 20:80 EtOAc/hexanes as the eluant gave 47c (75% yield) as a
brown solid: rnp 96-101°C; [120D -37.8° (e 0.93, CHC13); ‘H NMR: 67.76 (d, 2H,J=
7.5), 7.62 (d, 2H, J = 7.4), 7.40 (t, 2H, J = 7.4), 7.30 (t, 2H, J 7.3), 7.23(d, 1H, J
8.3), 6.49 (d, 1H, J = 6.6), 6.45-6.36 (rn, 2H), 6.09 (q, 1H, J = 9.3), 5.61 (q, 1H, J
9.1), 4.66-4.35 (ni, 5H), 4.23 (t, 1H.J= 7.1), 3.79 (s, 3H), 3.77 (s, 3H), 3.46 (s, 3H),
2.67 (m, 1H), 2.30-2.15 (in, 2H), 1.90 (m, 2H), 1.75-1.65 (ni, 2H); ‘3C NMR: 6173.3,
170.4, 159.8, 157.4, 155.2, 143.8, 141.1, 130.9. 129.9, 129.0, 127.5. 126.9, 125.0,
125.0 119.8, 117.5, 104.0, 97.9. 66.8, 56.9, 55.1, 52.0, 51.7, 47.0, 39.9, 35.0, 27.8,
22.0; HRMS (MH) calcd for C34H37N207, 585.25953; found, 585.25918.
General Procedure D: Removal of Dmb. A stirred solution of Frnoc-protected
dipeptide lactam (0.2 nimol) in CH2CI2 (8 mL) was treated dropwise with TFA (2
mL), stirred for 18 h, and evaporated to a residue that was punfied by
chrornatography.
Methyl (3S,9S)-3-N-(Fmoc)amino-2-oxo-2,3,4,7,$,9-hexahydro-1H-azonine-9-
carboxylate (50). Chromatography of the product from 47c (0.5 rnmol) using EtOAc
as the eluant gave 50 (95% yield) as a brown gum: 1H NMR: 67.76 (d, 2H, J= 7.4),
7.60 (d, 2H, J = 7.3), 7.39 (t, 2H, J 7.4), 7.30 (t, 2H,] = 7.4). 6.35 (d, 1H, J = 7.0).
6.25 (d, 1H,J l1.6),6.08 (q. 1H.J9.3),5.65 (ddd, 1H,J6.0, 11.0, 10.8),4.39-
4.38 (ni, 2H), 4.25 (m, 3H), 3.73 (s, 3H), 2.70 (ni. 1H), 2.30 (dd, 2H. J = 8.5, 8.7),
2.12 (rn, 1H), 1.87 (m. 1H), 1.75 (tu. 1H); ‘3C NMR: 6172.7, 172.0, 155.2, 143.7,
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143.6, 141.1, 130.1, 128.7, 127.5, 126.9, 124.9, 119.8, 66.8, 52.5. 52.1, 47.0, 34.1,
33.8, 22.5; HRMS (MH) calcd for C25H27N205. 435.19145; found, 435.19184.
General Procedure E: Methyl Ester Hydrolysis. A stirred solution of rnethvl ester
(0.5 mrnol) in 0.8 M CaCI2 in a 7:3 i-PrQH/H,Q soltition (10 mL) was treated with
0.5 M NaOH solution (2 mL). After 2 h, ether was added, and the phases were
separated. The aqueous layer was acidified with 1.0 N HC1 and extracted with EtOAc
(three times). The combined organic layers were washed with brine, dried over
MgSO4, flltered, and concentTated to give the acid.
(E,3$,9S)-3-N-(Fmoc)amin o-2-oxo-2,3,4,7,$,9-hexahyd ro-1H-azonine-9-
carboxylic acid (52). Hydrolvsis of 50 (0.4 rnmol) gave 52 (99% yield) as a white
solid: mp 190-193°C; 1H NMR (400 MHz, pyridine-d5): 68.90 (d, 1H, J = 11.0), 8.38
(d, 1H, ]= 7.1), 7.8 (m, 3H). 7.7 (t, 1H, J= 7.5), 7.35 (rn. 3H), 7.25 (t. 1H. J 9.0),
6.04 (q, 1H,] = 9.1), 5.75 (bs. 1H), 5.56 (m, 1H), 4.84 (t. 1H, J = 7.8), 4.69 (m, 1H),
4.55 (d, 2H,J= 7.16), 4.33 (t, 1H,J= 6.8), 2.95-2.88 (m. 1H), 2.5 (ni, 1H), 2.35 (rn,
1H), 2.20 (rn, 1H), 1.9 (m, 2H); 13C NMR: 6175.3, 174.1, 156.7, 145.2, 144.9, 142.1,
131.5, 129.3, 128.5, 127.9, 126.1, 120.8, 67.3, 52.9, 48.2, 41.4, 34.8, 31.0; HRMS
(MH) calcd for C,4H25N205, 421.17580 found, 421.17599.
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R = H or Dmb
P = Fmoc or Boc
E = I or SePh
Figure 15. Graphical Abstract
Macrocyclic and fused bicyclic dipeptides are complementaiy motifs for mimicly of
different types of 13-turn geornetiy. Macrocyclic dipeptide minhics have served as
precursors for the synthesis of their bicyclic counterparts using electrophilic
transannular cyclizations of 9- and 1O-membered ring lactams 62-65 to fomi
azabicyclo[4.3.O]- and [5.3.O]alkanone amino esters 66-69
3.2 Introduction
Peptides are important endogenous molecules responsible for a multitude of
roles in hurnan physiology; however, their therapeutic potential is often limited due to
their poor bioavailability, rapid metabolism and short duration of action. Peptide
;nimics have thus been developed to retain the desired biological effects of the parent
peptide and to rernove such undesirable characteristics.1 In this respect,
azabicyc1oX.Y.OJ-a1kanone ainino acids have proven to be effective dipeptide
rniinics, becatise their fused bicyclic ring system can constrain the backbone dihedral
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angle geometiy to induce secondary structures such as fi-tums. Although many
approaches have been conceived for making azabicycloalkanone amino acids2, few
exwnples have made practical use of common precttrsors for making a set of ring
systems.
The introduction of a set of dipeptide mimics is ofien desired to provide
detailed information about the conformation specifically required by the peptide to
effectively bind and activate the receptor. The acquisition of a set of
azabicycloalkanone amino acids requires, however, performing a series of multistep
syntheses because few dipeptide mirnics are commercially available. For exwnple, to
study opioid receptor like 1 (ORL1) receptor antagonists,3 replacement of the
commercially available fused-6,5 thiaindolizidinone amino acid with fused-6,5, -5,6
and -6,6 azabicycloalkanone arnino acids , reqtiired syntheses of 7, 7, and 5 steps
respectively from suitably protected amino dicarboxylic acids in overail yields
ranging from 45% to 61%. The use of such a tour de force of peptide scaffolds did
deliver analogs with remarkable potency and selectivity for the ORL1-receptor over
the other opioid receptor sub-types. For such structure-activity studies to become
more practical, however, more efficient methodology is needed for making such
mimics.
Considenng that electrophilic transannular cyclization of unsaturated
macrocyclic lactams of 9- and 1O-membered rings has been previously used to
prepare indolizidinone and quinolizidinone ring systems5, we have pursued this
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approach for converting macrocyclic dipeptide sunogates into their





















OMe (3S, 5R, 6R, 9S)-66 X = I (86%)
62 (33, 5R, 6R, 9S)-69: X = I (79%)
FmocHN
eflux FmocHNO2Me
63 (3S, 6R. 7S, 1OS)-67 (45%)
BOCHN2Me BocHNO2Me
64 (3S, 6R, 7S, 1OS)-68 (48%, 2 steps)
Scherne 8. Conversion ofrnacrocyclic dipeptides into bicyclic dipeptides by
electrophilic trwsannu1ar cyclization
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3.3 Results and Discussion
The set of 9- and 1 O-rnernbered unsaturated macrocyclic dipeptides 56-65 was
synthesized using our recently described protocol6 (Scheme 9). Briefly, suitably
Fmoc- and Boc-protected allyl- and hornoallylglycine 54-56 were coupled to
hornoallylglycine methyl ester 5$ using TBTU and DIFA, and to N
(Drnb)hornoallylglycine methyl ester 57 using HATU and DIEA in yields valying
between 75% and 87% (Drnb = 2,4-dimethoxybenzyl). Annulation of the dipeptides
59-61 bearing t-wo olefinic side chains was achieved using the first generation of
Grubbs catalyst to afford the macrocyclic unsaturated lactams 62-64 in yields
between 71% and 77%. finally, the Dmb group, which was essential for the
annulation of the 9-membered lactams, was rernoved by treatrnent with 50% TFA in
CH2C12 to afford quantitatively secondaiy amide 65.
The electrophilic transannular cyclization was initially performed on 9- and
lO-membered lactams 62-65 using iodine as the source of electrophile (Scheme 8).
Treatment of the Frnoc-protected, 9-rnembered lactam 65 with four equivalents of 12
in THf at reflux gave hvo isomeric bicyclic products (3$, 5R, 61?, 95)- and (3$, 5$,
6$, 95)-66 m 46% and 27% respective yields (see below for stereochemical
assignments). On the other hand, treatment of the corresponding tertiary Dmb-arnide















61 p = Boc; R = H; m = 2
FrmcHN
O CO2Me
ii 1FA E 62P=Fnc;R=;olefin=Z;m=1
‘I 63P=Fnc;R=H;olefin=E;m=2CH2CI2 64P8oc; RH;ofinEm2
(99/o)L*.65p=Fnc;R=H:oIefin=Z.m=1
Scheme 9. Unsaturated macrocyclic dipeptide lactam synthesis° DMB = 2,4-
dimethoxybenzyl
(3S, 6R, 7$, 1OS-Azabicyclo[5.3.O1a1kanone 67 was similarly prepared in 45% yield
by treating Fmoc-protected secondary lactam 63, bearing the trans double bond, with
iodine in THF at reflux. Loss of the Boc group was observed in the reaction of the
corresponding Boc-protected 1O-rnembered macrocycle 64 with iodine in THF;
however, pyrroloazepinone 67 with the sarne stereochernistry as its frnoc counterpart
could be isolated in 48% overali yield after reprotection using Boc2O and
triethylamine in CH2CI2
In light of the effective transannular cyclizations tising iodine, a cursoiy
investigation of alternative electrophiles was peiforrned using macrocycle 62 in order
to examine effects on reaction stereochemistiy and product structure. Treatrnent of 62
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with bromine or N-brornosuccinirnide did not afford bicycle; instead. brornination of
the arornatic ring was observed by LC/MS. Also treatement of 62 with mercuric
acetate did flot lead to bicyclic products. Alternatively, exposure of dipeptide 62 to 4
eq of phenylselenium bromide in Il-1F at reflux provided bicyclic arnino ester 69 in
79% yield (Scheme 8).
The assignment of the structures and stereochernistiy of the different
azabicyclo[X.Y.Olalkanone arnino acids vas perfonned using NMR spectroscopy and
X-ray ciystallographv (Supporting Information). For bicycle 66, the ring protons
carne at distinct chemical shifts and their sequential order was assigned using a
COSY experiment. Coupling behveen the downfield carbamate proton and the proton
of the adjacent backbone carbon was used as the starting point for tracing the through
bond connectivities of the various protons around the bicycle. With the through bond
connectivities ascertained, the through space coirnectivifies observed in the NOESY
spectra were used to assign relative stereochemistry. In the NOESY spectrum of
indolizidinone (5R, 6R)-66, long distance transfer of magnetization between the C3
proton and the iodinated C5 and ring-fusion C6 protons, respectively, confirrned the
concave bicycle structure and the trans relation between the ring-fusion proton and
the iodide (Figure 16). In (58,65)-66, the bridgehead stereochemistiy was assigned
based on NOE with the C8 beta-proton which carne downfield relative to its alpha-
proton counterpart due to the anisotropic effect of the C9 carboxylate (beta is on the
sarne face as the C3-arnine).7 In the cases of fused-7,5 systems 67 and 68. the
relative stereochemisti-v of the newly fonned centres vas confinned by X-ray
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(56•8H
FmœHN 1 FmocHN t
COMe CO2Me
(3S. 5ft 6R 9S)-66 (3S, 5S: 6S, 9S)-66
Figure 16. NOESY conelations observed for cornpounds (38, 5R, 61?. 9g-66 and
(3$. 58, 6$. 95}.66
‘I
‘À—’
fi.ure 17. X-rav crvstal structures of 67 (to) and 68 (bottom.
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FmocHN i FmocHN 1
COMe o CO2Me
(3S, 5R, 6R, 9S)-66 (3S, 5S, 6S, 9S)-66
Figure 16. NOESY correlations observed for cornpounds (33, 5R, 6R, 93)-66 and












fiure 17, X-rav crvstal structures of 67 (too and 68 (bottorn.
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ciystallographic analysis of ciystals from acetonelhexanes and ethyl acetate/hexanes,
respectively (Figure 17). $ The cis relationship between the iodide and the bndgehead
proton and the convex bicycle was observed in both structures.
In concurance with an earlier computational study of the parent
pyrroloazepinone,9 in their respective X-ray structures, the psi and phi dihedral angles
within bicycles 67 (-64.1°; -49.4°) and 68 (-63.5°; -46.6°) were sirnilarto ideal values
for the central residties in a type I f3-turn t_300; 9O0);b0 however, less similar than the
dihedral angles of the parent macrocyclic dipeptide, which exhibited psi = -20° and
phi = -107° in the X-ray structure of a model peptide.11 Moreover, the phi dihedral
angle was consistent with an inverse y-mm (phi = -70 to _850).12 Power to pass from
macrocycle to bicycle constrained dipeptide surrogates provides thus opportunity to
explore different mm geometry with rnirnics derived from a common reaction
sequence.
3.4 Conclusion
A novel effective approach for the synthesis of azabicyclo[4.3.0] and
[5.3.OJalkanone arnino esters has been developed featunng the electrophilic
transannular cyclization of 9- and 10-inernbered macrocyclic dipeptides. This
approach offers potential for converting one tum mirnic into another. Furtherrnore,
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the resulting iodide provides opportunity for the introduction of side-chains onto the
heterocycte ring. We are now developing these avenues for peptide rnimiciy.
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3.7 Considérations mécanistiques
Bien entendu, les résultats présentés dans le Schéma $ peuvent mener vers
divers points d’interrogation concernant la régiosélectivité et la stéréosélectivité
obtenues lors de la réaction de cyclisation transaimulaire. Malgré l’utilisation de cette
stratégie dans plusieurs cas, seulement quelques travaux ont été publiés avec des
considérations mécanistiques. Au début des années 1980, cette méthodologie a été
utilisée pour la synthèse de dindolizidine.5a En effet, des lactarnes de neuf membres
comportant une double liaison cis entre les carbones 5 et 6 ont été traités avec de
l’acétate de mercure suivi d’une réduction au NaBH4 pour obtenir les
azabicyclo [4.3.0 .]alcanes. Malheureusement, puisque l’intermédiaire aikylé de
mercmre n’a pu être isolé, aucune discussion sur la stéréochimie n’a été faite.
D’autre part, des lactames de 10 membres pourtant une double liasion trans entre les
carbones 5 et 6 ont été utilisés pour synthétiser des azabicyclo[4.4.0]alkanone.13 Les
auteurs ont utilisé le brome con;me électrophile et obtenu une stéréochimie anti entre
l’atome d’hydrogène en tête de pont et l’atome de brome. Cette stéréochimie a été
expliquée par une addition du brome sur la liasion double pour former un
intermédiaire dibromé suivi d’une attaque par l’atome d’azote de l’amide pour former
le bicycle. Dans un autre cas un peu plus différent des cas discutés dans le présent
chapitre, des lactaines de neuf membres comportant mie liaison double trans entre les
carbones 5 et 6 ont été transfonnés soit en azabicyclo[4.3.Ojalcanone ou en
azabicyclo[3.4.OJalkanone.s Les auteurs ont pu établir qu’à température pièce le
macrocycle formé par une réaction diastéréosélective Aza-Claisen subissait une
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relaxation conformationelle et que chaque confonnère différent était responsable de
la formation d’un bicycle différent.
Dans notre cas, on observe tout d’abord deux produits de cyclisation
transannulaire lorsque le produit de départ est l’amide secondaire 55. Dans les deux
cas, on observe une stéréochimie relative anti par rapport à l’atome d’iode et
l’hydrogène en tête de pont. Cette stéréochimie relative peut être expliquée par
l’attaque de la liasion double cis sur l’iode pour former un ion iodonium cyclique
(Figure 1$). Vu la petite taille du cycle, seul la face extérieure de l’oléfine pourra
attaquer la molécule d’iode pour former l’iodonium cyclique. Ce cycle tendu est par
la suite ouvert avec inversion de configuration lorsque l’atonie d’azote de la fonction
amide attaque l’atome de carbone le plus près spatialement du nucléophile pour
donner les produits (3$, 5R, 6R, 95)-66 et (3$, 5$, 6$, 95)-66. Malheureusement, les
règles de Baldwin14 ne peuvent être utilisées ici pour prédire lequel des deux
régioisomères possible est le plus apte à être produit. En effet, dans les deux cas de
régioisonlère possible, on observerait soit une cyclisation 5-exo-tet ou 6-endo-tet.
L’obtention des deux différents stéréoisomères pourrait être expliquée par un
équilibre entre deux conformations pennettant ainsi aux deux faces de l’oléfine
d’attaquer l’iode. Toutefois, lorsque l’amide tertiaire réagit, seulement le produit (3$,
5R, 6R, 95)-66 est fonné. Ceci pourrait être expliqué par le fait que le confonnère de
type B est fortement énergétiquement désavantagé par rapport au confonnère de type
A par une interaction de type tension allylique A1,3 entre le groupenient benzylique
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Conformer. type D (3$, 6H. 73.103)36
Figure 18. Considérations mécanistiques
Dans le cas de la cyclisation de l’amide cycle de 10 membres, la stéréochimie
relative syn peut encore une fois être expliquée par la formation d’un intermédiaire
iodonium cyclique. Cette fois-ci, la liaison double trans située entre les carbones 6 et
7 mène â une stéréochimie relative svn inversement â la stéréochimie relative anti
obtenue avec le lactame de 9 membres comportant une double liaison cis. Cette fois,
la régiosélectivité peut être rationalisée avec les règles de Baldwin. En effet, le
produit obtenu provient d’une cyclisation 5-exo-tet ou 7-endo-tet alors que l’autre
régioisomère serait issu d’une cyclisation 6-exo-tet ou 6-endo-tet et, selon les règles
de Baldwin, la formation d’un cycle par une cyclisation 6-endo-tet n’est pas favorisée.
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L’obtention d’un seul produit est toutefois plus complexe à rationaliser. Encore une
fois, deux conformères sont possiblement en équilibre et le confornière de type D
semble être l’unique conformère réactif. Cette différence de réactivité entre les deux
conformères pourrait possiblement être expliquée par l’orientation du carbonyle de
l’amide et celui de l’ester du conformère de type C qui forme un fort moment
dipolaire défavorable.
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4.1 Abstract







‘I t ‘ ii ‘NHcc NH
)î—. i”
NH
Figure 1 Graphical Abstract
The 9-(4-brornopheny!)-9-fluorenyl (BrPhf) group has been developed as a
nove! safety-catch amine protection. This relative!y acid-stable protecting group can
be successfully activated by pa!!adium-catalyzed cross-coup!ing reaction of the axyl
bromide with morpholine and then c!eaved effectively under mild conditions using
dich!oroacetic acid and tnethy!si!ane. Complementaiy conditions are reported for
selective removal of the BrPhF group in the presence of tert-butyl esters and
carbamates as well as deprotection of tert-butyl esters and carbamates in the presence
of BrPhF amines.
4.2 Introduction
Protecting groups have been essential for controlling the reactivity of amines
in organic synthesis, peptide science, and medicina! chemisfly)’2 In the context ofour
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research on the synthesis of peptide mimics,3 the 9-phenyl-9-lluorenyl (Phf) group
has been used to prevent the loss of enantiomeric purity during the employrnent of
various amino carbonyl compounds.4 The PhF group offers several advantages as
amine protection. The steric bulk created by the PhF group acts as a barrier that
prevents deprotonation of Œ-amino carbonyl compounds at the a-carbon. The PhF
group is significantly more stable under acid conditions relative to the trityl grottp
because of the anti-aromatic character of the 9-phenyl-9-fluorenyl carbocation.5
Furthermore, if deprotonation of the Œ-carbon occurs under severe conditions, the
PhF anion can act as a leaving group and eliminate to furnish an imine intermediate
prior to reprotonation and epimenzation.6 The PhF group is usually rernoved by
hydrogenolysis7 and by solvolysis with treatment under strongly acidic conditions.8
Ahematively, the Phf group lias been removed using sodium or lithium in liquid
ammonia,9 TMSOTf in the presence oftriethylsilane,1° and iodine in MeOH.11
Perceiving the advantages of having a chemical means for rendering the PhF
group cleavable under mildly acidic conditions, we considered that p
aminophenylfluorenyl cations would be significantly more stable than the parent Phf
cation. Strategies have been conceived for generating p-aminobenzylic intermediates
from suitable para-substituted benzyl derivatives. For example, the p-nitrobenzyl
ester lias been used in the synthesis of carbapenems and removed by nifro group
reduction and solvolysis.12 More recently. p-halobenzyl ethers were reported to be as
stable as normal benzyl ethers yet cleavable using a two-step process featunng
catalytic amination ofthe aiyl halide and solvolysis with acid.’3
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In our previous work, we ttsed the 9-(4-bromophenyl)-9-fluorenyl (BrPhF)
group in a linking-protecting grottp sfrategy for the synthesis of enantiopure
norephedrines on solid support.14 The BrPhF group proved tolerant to sirnilar
chemistry previously developed with Phf-protected arnino acids before it reacted in a
palladiurn-catalyzed cross-coupling with bisQinacolato)diboron ester to give a
suitable boronate for attaching the PhF-protected substrate to aryl halide resins.
Pursuing the developrnent of this protecting group, we demonstrate now that the
BrPhf group can be employed as a safety-catch15 amine protecting group which cmi
be released by catalytic arnination followed by treatment with mild acid.
4.3 Results and Discussion
The relative acid stability of the PhF group and an analogue bearing a p
muinophenyl substituent was studied by the synthesis of N-(9-(4-rnorpholinophenyl)-
9-fluorenyl)alanine methyl ester 71 and companson of its reactivity under acid
conditions with N-(PhF)alarnne methyl ester (Scheme 10, MPf = 9-(4-
rnorpholinophenyl)-9-fluorenyl).
Both N-(PhF)- and N-(BrPhf)alanine methyl esters were synthesized as
previously described.14’16 Amination of BrPhF-AIa-OMe (70) with morpholine using
5 mol% of Pd(OAc)2, (±)-BINAP, and excess Cs2CO3 provided N-(MPF)alanine
methyl ester (71) in 81% yield. Competitive cleavage ofN-(Phf)alanine methyl ester
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Scheme 10. Svnthesis and Solvolysis ofN-(MPF)alanine Estersû a Kev: (a)
Pd(OAc)2, (±)-BINAP, Cs2CO3, morpholine, PhCH3, reflu: (b) CHCI2CO2H,
Et3$iH. CH2CI2; (c) LiOH. H2O/dioxane (d) O-teri-butyl trichioroacetamidate,
CH2CI2; (e) Boc2O, Et3N, CH2C12.
and N-(MPf)alanine methyl ester (71) vas performed by treating an equimolar
mixture of the protected arnino acids in CH2C12 with trichioroacetic acid and
triethylsilane. Under these conditions, the 9-(4-morpholinophenyl)-9-fluorenyl group
was cleaved within 5 min as monitored by HPLC, which detected 9-(4-
morpholinophenyl)-9-lluorene (72). The PhF-protected methyl ester remained stable
and no trace corresponding to PhFH was observed by HPLC. Ernploying the milder
dichioroacetic acid under the saine conditions, complete solvolysis of N
(MPF)alanine methyl ester (71) occurred within 30 min.
r—1 RCH3
=“4 ROH (99 ¾)
L..,.. 5 R = t-Bu (81 %)
2 R Me (81 ¾)
6 R t-Bu (79 %)
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11e selective removal of the BrPhF group from an amino tert-butyl ester was
next studied to estabiish cleaving conditions tolerant to a more acid-labile group. N
(BrPhf)Aianine 73 was synthesized as previously described by hydrolysis of methyl
ester 70 using LiOH.14 N-(BrPhF)alanine tert-butyl ester (74) was then prepared in
81% yieid by treating the amino acid with O-tcrt-butyi trichloroacetirnidate17 in
dichioromethane foliowed by chrornatography. The conversion of N-(BrPhF)aianine
tert-butyl ester (74) to N-(MPF)alanine tert-butyl ester (75) was achieved in 79%
yield using the palÏadium-cataiyzed reaction conditions mentioned above. Exposure
of a 1:1 mixture of N-(PhF)alanine tert-butyl ester18 and N-(MPF)aianine tert-butyl
ester (75) to dichioroacetic acid and triethylsilane in CH2CY2 caused selective
deprotection in 30 min as monitored by HPLC which indicated the appearance of
morpholine 72 and no traces of 9-phenyffluorene nor any con-esponding acids after
30 min. Treatment of N-(MPF)alanine tert-butyl ester (75) with 20 equiv of
dichioroacetic acid min 2 equiv of triethylsilane in CH2CI2 for 30 min followed by
addition of 22 equiv of tnethylamine and Boc2O provided N-(Boc)alanine tert-butyl
ester in 84% yield. Altematively, alanine tert-butyl ester could be isolated as its
hydrochionde sait in 89% yield afier MPF deprotection, extraction with dilute
aqueous HC1, and iyophilization.
To explore more deeply the strengths and limitations of this protection group
N-(BrPhF)a1aninyl(-Boc)lysine tert-butyl ester (80) tvas synthesized by coupling
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13 R = CO2Me (82 %)
14R= Fmoc(86%)
Scheme 11. Synthesis and Solvolysis ofN-(MPF)-Protected Dipeptides’ ‘ Key: ta)
DCC, HOBt, DIFA, CH2C12; (b) Pd(OAc)2, (±)-BE’1AP, Cs2CO3, morpholine,
PhCH3, reflux; (c) (j) CHC12CO2H, Et3SiH, CH2C12, (ii) Et3N, C1CO2Me; (d) (i)
CHC12CO2H, Et3SiH, CH2C12, (ii) Et3N, frnocOSu.
acid 73 with (j-Boc)1ysine tert-butyl ester using DCC and HOBt in 75% yield
(Scheme 11).
Conversion to the N-(MPF) dipeptide 81 tvas effected as previously described
in 78% yield. The MPF-protected amine vas selectively deblocked using
CHC12CO2H and Et3SiH and the ftee amine was subsequently converted in situ to a
methyl carbarnate using methylchlorofonnate aiid Et3N in 82% yield. The 1H NMR
spectrum of the cnide mixture showed a one-to-three ratio of singlets corresponding
to the methyl and tert-butyl protons for the carbamates indicating that no deprotection
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of the Boc-protected amine had occurred. The LC-MS analysis of the cmde mixture
also confirmed that Boc-deprotection did flot occur during the sequence. Using a
sirnilar protocol, N-(fmoc)a1anmyl(.-Boc)1ysine tert-butyl ester (83) was synthesized
by deprotecting the MPf-amine aiid reprotectmg using FmocOSti and Et3N in 86%
yield.
Selective removal of tert-butyl esters in the presence of Phf amines bas been
recently reported to be effectively accomplished using ZnBr2 in CH2C12.18 When
BrPhF-Ala-OtBu (74) was subrnitted to these conditions, N-(BrPhF)alanine was
obtained in 82% yield (Scheme 12). The acid stability of the BrPhF grotip was
demonstrated by the selective removal of the Boc group using C12CHCO2H which
afforded dipeptide $4 in 72% yield, as well as by removal of both the tert-butyl ester
and carbamate groups using the stronger acid C13CCO2H to give dipeptide 85 in 73%
yield. These resuits demonsfrated that the orthogonal nature of the BrPhF/tert-Bu
combination of protecting groups can be utilized in botli directions.
4.4 Conclusion
In sum, we have demonstrated the utility of the 9-(4-bromophenyl)-9-
fluorenyl group as safetv-catch amine protection. Sirnilar to the PhF group, the BrPhf
group may be used to ensure the configurational stability of amino carbonyl
compounds. This relatively acid stable group can then be rendered susceptible to mild
acid solvolysis by palladium-catalyzed amination. The potential of this strategy bas
C Chapitre 4 77
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Scheme 12. Selective tert-Butyl Ester and Carbamate Cleavage
been illustrated by the palladium-mediated selective cleavage of the BrPhF-amine in
the presence of the acid labile tert-butyl ester and carbarnate groups and
complementarv removal of either Boc grotip or both Boc and tert-butyl ester groups
in the presence of the BrPhF-amine. Considering the need for selective methods for
removirlg acid labile protecting groups, the BrPhf group shotild find general utility in
the synthesis of amines.
5.5 Experimental Section
(2S)-N-(BrPhF)Alanine tert-butyl ester (74). To a stirred suspension of (28)-N-
(BrPhF)alanine (540 mg. 1.32 minol. prepared according to ref 14) in CH2CI2 (4 mL)
was added O-tert-butyl trichioroacetimidate (578 mg, 2.64 rnmol). The mixture was
stirred for 1 day, filtered, evaporated, and resubmifted to Ilie same conditions as
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above for 2 days. Filtration and evaporation, followed by chromatography (5%
EtOAc in hexanes) gave ester 74 (495 mg, 81%) as a clear ou: [ŒJ20D -51.3 (c 1.5,
CH3OH); ‘H NMR 67.72 (d, J = 7.8 Hz, 2H) 7.40-7.26 (m, 10H), 3.09 (s, 1H), 2.69
(q, J= 7.1 Hz, 1H), 1.23 (s, 9H), 1.13 (d, J 7.1 Hz, 3H); ‘3C NMR 6175.4, 148.9,
148.6, 143.7, 140.3, 139.7, 130.9, 127.99, 127.96, 127.7, 127.6, 127.5, 125.4, 124$,
120.7, 119.7, 119.5, 80.1, 72.3, 51.6, 27.5, 21.8; HRMS calcd for C26H27BrNO2 [M +
H1 464,1227, found 464.1219.
General Procedure for N-(MPF)amine Synthesis. The BrPhF-protected amine (2.5
mmol) was dissolved in 5 mL of diy and degassed toluene and treated with Pd(OAc)2
(28 mg, 0.13 mmol), BINAP (79 mg, 0.13 mmol), and diy Cs2CO3 (4.07 g, 12.5
mmol). followed by morpholine (257 iL, 3.0 mmol). The mixture was heated at
reflux and stirred for 24 h, filtered on Celite, washed with CH2C12, and the combmed
fikrate and washings were evaporated. The residue was chromatographed to afford
the MPf-protected amine.
(2S)-N-(MPF)Alanine methyl ester (71). Chromatography of the product from 70
(1.00 g, 2.4 mmol) using 20% EtOAc in hexanes as eluant gave 71(820 mg, 81%
yield) as a yellowish solid: mp 62-64 C; [u120D -121.1° (c 2.2, CH3OH); ‘H NMR
6.6$ (dd, J 7.5 Hz, 2.5 Hz, 2H), 7.33 (m, 5H), 7.23 (m, 3H), 6.77 (d, J = 8.9 Hz,
2H), 3.82 (t, J = 4.8 Hz, 4H), 3.30 (s, 3H), 3.10 (t, J = 4.8 Hz, 4H), 2.77 (q, J = 7.0
Hz, 1H), 1.12 (d, J 7.0 Hz, 3H); ‘3C NMR 6177.1, 150.1, 149.4, 148.8, 140.6,
139.9, 135.6, 128.0, 127.6, 127.2, 126.9, 125.8, 124.8, 119.8, 119.7, 115.1, 72.4,
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66.7, 51.4, 51.2, 49.0, 21.4; HRMS caicd for C27H28N2O3Na [M + Naj 451.1989,
found 451.1992.
General Procedure for MPF-Solvolysis. The MPF-protected amine (0.4 rnmol) was
dissolved in 4 mL of CH2CI2, treated with dichioroacetic acid (660 pL, $ mmol) and
triethylsilane (12$ j.tL, 0.8 mrnol), stirred at rt for 30 mm, and evaporated on a rotary
evaporator. The residue vas dissoÏved in 10 mL of Et20 and treated with 10 mL of
0.5 M HC1 solution. The aqueous phase was separated, washed twice with 5 mL of
Et20, and lyophilized to give the unprotected amine as a hydrochioride sait.
Altematively, after complete solvolysis of MPF-amine was observed by TLC, the
reaction mixture was treated with 22 equiv of Et3N followed by 200 mol % of either
Boc2O, methyl chloroformate or FrnocOSu, stirred ovemight, diluted with CH2C12,
washed with H20, 0.5 N HC1, and brine, dried over MgSO4, and concentrated. The
cnide residue was purifled by flash chrornatography2° to give, respectively, the Boc-,
methyl carbamoyl- or Frnoc-protected amino ester.
(2S)-Alanine tert-butyl ester hydrochloride (68). Lyophilization of aqueous layer
after solvolysis of 6 (190 mg, 0.4 mmol) gave 6$ (65 mg, 89% yield) as a white solid:
mp 170°C dec (lit.19 mp 168°C dec); [uJ20D 6.1° (e = 1.0, EtOH) [lit.19 [U]20D 3.0° (c =
2.0, EtOH)J; HRIvIS calcd for C7H15NO2Na [M +Na1 168.0995, found 168.0987.
N-(Fmoc)alaninyl- o -(Boc)Iysine tert-butyl ester ($3). Chromatography of the
product from 81(30 mg, 0.11 inrnol) using 30% EtOAclhexanes as eluant gave 83 as
a white powder (22.0 mg, 86% yield): rnp 67-69°C; [c:J2°n -16.5° (c 1.0, CHC13); 1H
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NMR ¶76 (d,] 7.5 Hz, 2H), 7.59 (d, J = 7.4 Hz, 2H), 7.39 (t, J 7.2 Hz, 2H),
7.31 (tt, J 7.5, 1.2 Hz, 2H). 6.59 (d,] 6.7 Hz, 1H), 5.59 (s, 1H), 4.69 (s, 1H), 4.45
(m, 1H), 4.38 (U, J = 7.0 Hz, 2H), 4.29 (rn, 1H), 4.22 (t,] = 7.0 Hz, 1H), 3.06 (U. J =
5.5 Hz, 1H), 1.84 (in, 2H), 1.65 (in, 1H), 1.52-1.27 (in, 6H), 1.46 (s, 9H), 1.42 (s,
9H); 13C NMR 6171.8, 171.0, 156.0, 155.8, 143.6, 141.1, 127.6, 126.9, 125.0, 119.8,
82.1, 79.0, 67.0, 52.4, 50.3, 47.0, 39.9, 33.5, 29.2, 28.3, 27.8, 21.9, 18.6; HRMS
calcd for C33H45N307 [M +Nar 618.3 1389, found 618.3 1389.
4-t4-(9H-Fluoren-9-y1)phenyllmorpholine (72). The N-arytamine 72 was isolated
by flash chrornatography as the second eluting compound of the crude residue in the
solvolvsis of the MPF-protected amine 5: ‘H NMR 67.82 (d, J 7.5 Hz, 2H), 7.42-
7.26 (in. 6H), 7.03 (d,J= 8.5 Hz, 2H), 6.84 (d,]= 8.3 Hz, 2H), 5.02 (s, 1H), 3.87 (t,
J = 4.8 Hz, 4H). 3.15 (t, J = 4.8 Hz, 4H); 13C NMR 6149.7, 147.9, 140.5, 128.7,
126.9, 126.8, 124.9, 119.4, 115.5, 66.6, 53.3, 49.0; MS (ESI, ,n/z) 328.3 (MH).
(2S)-N-(BrPhF)Alanine (73). A stirred solution ofN-(BrPhf)alanme tert-butyl ester
(75) (45 mg, 0.1 mmol) in 0.5 mL of dichioromethane was treated with ZnBr2 (110
mg, 0.5 mmol) at rt, stirred for 24 ii, treated with water (2 mL), stirred for 2 h, wid
treated with CH2C12 (5 mL). The orgwiic phase was separated. The aqtieotis layer tvas
extracted twice with CH2C12 (2 mL). The organic portions were combined, dried,
fihered, and evaporated. The residue vas chromatographed (50% EtOAc:hexanes
containing 1% AcOH) to afford 32.5 mg (82% yield) ofN-(BrPhF)alanine as a white
solid: mp 116-118°C; [.]20 -16.5° (c 1.1. CH3OH). The spectroscopic data were
identicat to those reported)4
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N-(BrPhF)-L-AlanyI-u-(Boc)-L-Jysine tert-but I ester (80). N-(BrPhF)alanine (73),
(514 mg, 1.26 mmol). DCC (311 mg. 1.51 rnmol), and HOBt (204 mg. 1.51 mmol)
were dissolved in 13 mL of CH2C12, treated with -(Boc)1ysine tert-butyl ester (380
mg, 1.26 mrnol), stirred for 24 h, filtered, washed with a 10% HC1 solution, saturated
NaHCO3, and brine, dried over MgSO4, filtered, and concentrated to a residue that
purified by chromatography (50% EtOAc/hexanes) to afford 651 mg (75% yield)
of 80 as a white powder: mp 83-85°C; []20D -20.8° (c 1.0, CH3OH); 1H NMR 67.96
(d,] 7.6 Hz, 1H), 7.72 (d,] 7.5 Hz, 1H), 7.62 (d, J 7.5 Hz, 1H), 7.44-7.25 (m,
9H), 7.05 (t,] = 7.5 Hz, 1H), 4.68 (m, 1H), 4.27 (q,] = 7.2 Hz, 1H), 3.10 (m, 2H),
2.47 (q,J= 7.1 Hz, 1H), 2.25-1.80 (bs, 1H), 1.75 (ni, 1H), 1.62 (m, 1H), 1.54 (s, 9H),
1.43 (s, 9H), 1.54-1.43 (m, 2H), 1.29 (m, 2H), 1.09 (d, J = 7.1 Hz, 3H); ‘3C NMR
6175.1, 171.8, 156.1, 148.9, 147.3, 143.5, 141.4 140.0, 131.6, 128.9, 128.8, 128.2,
128.1, 127.7, 126.1, 124.3, 121.4, 120.4, 120.2, 82.2, 79.1, 73.0, 52.8, 51.9, 40.4,
33.0, 29.5, 28.5, 28.1, 22.2, 21.8; HRMS calcd for C37RBrN3O5Na [M + Na]F
714.25 131, found 714.25002.
N-(BrPhF)-L-AIanyl-L-Iysine tert-butyl ester ($4). N-(BrPhF)alaninyl( u -
Boc)lysine tert-butyl ester 80 (50 mg, 0.072 mmol) was dissolved in 150 jiL of
CH2C12, treated with 150 1.iL of C12CHCO2H, and stirred for 21 h. The mixture was
diluted with 5 mL of CH2C12, washed with saturated NaHCO3 (2 x 3 mL), dried over
MgSO4, concentrated, and purifled by chromatography (5% MeOH/CHC13 + 1%
Et3N) to give amine 84 (30.7 mg, 72% yield) as a brownish ou: [e:120D 39.7° (e 2.6,
CHCY3); H NMR (CD3OD) 67.80 (d, J = 7.5 Hz, 1H), 7.73 (d, J = 7.5 Hz, 1H), 7.46-
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7.26 (m, 9H), 7.0$ (dt,J= 1.0, 7.6 Hz, 1H), 4.06 (m, 1H), 2.90 (ni. 2H). 2.44 (q,J
7.1 Hz, 1H), 1.73 (m, 1H), 1.64 (ni, 3H), 1.53 (s, 9H), 1.29 (m, 2H), 1.0$ (d,J= 7.1
Hz, 3H); 13C NMR (CD3OD) 178.6, 172.5, 150.5, 149.3, 145.3, 142.4, 141.6, 132.3,
129.9, 129.7, 129.3, 128.4, 127.2, 125.8. 122.0, 121.1, 83.5, 74.2, 53.8, 53.3, 40.5,
33.1, 28.3, 28.0, 23.5, 21.5; HRMS calcd for C32H39BrN3O3Na [M + Hj 592.21693,
found 592.2 1666.
N-(BrPhF)-L-AIanyl-L-]ysine (85). The BrPhF-protected dipeptide 80 (40 mg,
0.058 mmol) vas dissolved in 300 1.tL of CH2C12, treated with CI3CCO2H (236 mg,
1.44 mmol), and stirred for 72 h. The mixture was diluted with 5 mL of CH2CI2,
washed with 0.1 N HC1 (2 x 3 mL), lvophilized, triturated with Et20, and purified on
reversed-phase preparative HPLC to afford 85 (22.6 mg. 73% yield) as a white gum:
[120D -3.1° (c 1.1, CH3QH); 1H NMR (D20) ¶78 (d, J 7.5 Hz, 1H), 7.66 (d, J =
7.4 Hz, 1H), 7.47 (t.J= 7.2 Hz, 1H), 7.32 (ni, 3H) 7.21 (d,J 8.5 Hz, 2H), 7.12 (m,
2H), 6.98 (U, J = 8.6 Hz, 2H), 3.47 (t, J = 6.6 Hz, 1H), 3.12 (q, J = 6.6 Hz, 1H), 2.87
(m, 2H), 1.51 (m, 2H), 1.33 (ni, 2H), 1.19 (d,J= 7.1 Hz, 3H), 1.01 (in, 2H);’3C NMR
(D20) 175.5, 170.1, 140.8, 140.3, 140.1, 131.6, 130.8, 130.6, 129.0, 127.9, 126.9,
126.8, 124.9, 122.0, 120.9, 120.4, 73.3. 53.2, 52.7, 38.6, 29.5, 26.0, 21.6, 16.9;
HRÎvIS calcd for C28H31BrN3O3 [M +Hj 536.15433,found 536.15304.
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Les deuxième et troisième chapitres ont montré le développement de deux
méthodologies de synthèse permettant d’obtenir deux différents types de mimes de
tours (3. En effet, le chapitre 2 traite d’une stratégie de synthèse permettant d’obtenir
des dipeptides macrocyliques tandis que le chapitre 3 en discute une autre permettant
d’obtenir des dipeptides bicycliques. Tel que mentionné dans le chapitre 1,
l’insertion de ces différents mimes dans des peptides permet d’obtenir plus
d’information sur la conformation du peptide requise pour se lier avec le récepteur et
ainsi induire un effet biologique.
Toutefois, malgré que le développement de la synthèse peptidique sur support
solide1 ait permis de produire rapidement et efficacement des quantités appréciables
de différents peptides, l’incorporation de mimes peptidiques dans des peptides est
souvent limitée par la synthèse multi-étapes en solution requise pour la mise au point
de ces différents mimes. De plus, puisque la synthèse d’une quantité appréciable
d’une combinaison de différents mimes demande beaucoup d’efforts synthétiques,
l’emplacement de l’incorporation de ces derniers mimes doit être planifié et ne
permet pas de sonder toutes les possibilités conformationnelles d’un peptide.
Évidement une des solutions à ce problème consisterait à faire la synthèse du mime
peptidique sur phase solide au fur et à mesure que la chaîne peptidique est construite








figure 19. Synthèse de mimes de tours f3 cycliques sur support solide
p
ermettrait de faire un balayage conformationnel en remplaçant chaque duo d’acides
aminés formant le peptide par un mime peptidique.
Quelques groupes de recherches ont tenté de mettre au point des
méthodologies de synthèse sur support solide qui permettraient d’obtenir rapidement
des mimes peptidiques qui pourront être testés pour connaître leur activité biologique.
Par exemple, une stratégie permettant de synthétiser des mimes de tours f3 cycliques a
été mise au point en utilisant quatre blocs de construction simples (Figure 1 $)2 En
effet, un acide aminé est utilisé en position j + 2, une amine primaire permet de
mimer l’interaction de la chaîne latérale de l’acide aminé en position i + 3, tandis que
celle de la position i + 1 est introduite par l’utilisation d’un Œ-bromo acide.
finalement la synthèse du mime peptidique peut être effectué sur support solide en
utilisant une résine de polystyrène aminométhylée comportant un espaceur formé
d’un lien disulfure et terminé d’un mesylate. En utilisant cette stratégie, une
chimiothèque de 172 membres a pu être synthétisée ce qui a permis la découverte
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d’un ligand se liant au récepteur de la somostatine hSST5 avec une valeur d’1C50 de
87 nm.











NHB0C R = Pr, ,-Pr, Bu, sec-Bu,
i-Bu, CH2—Cy, CH2CH2—Cy
= HMBA-NH-PEGA0
Schéma 13. Synthèse de différents mimes peptidiques bicycliques sur support
solide.
Plus récemment, une stratégie générale de synthèse de mimes peptidiques sur
support solide a été développée afin d’obtenir différents dipeptides bicycliques. Cette
méthodologie tire profit d’un aldéhyde masqué installé en fin de chaîne peptidique
qui réagit pour former un ion N-acyliminium qui est à son tour trappé par différents
nucléophiles (Schéma 13). En effet, tout dépendamment de la chaîne latérale
présente sur le dernier acide aminé du peptide en construction, trois différents types
de mimes peptidiques bicycliques peuvent être synthétisés avec d’excellentes puretés.
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L’utilisation d’un acide aminé comportant un groupement aryle sur la chaîne latérale
permettra une réaction de type Pictet—Spengler. D’un autre côté, si un nucléophile est
I 1) 25% pipéridinelDMF O.
2) Frnoc-Phe-OH, HBTU, HS
t HOBt, DIEA, DMF
I Phe—Leu -f
FmocHN”jf””J 3) 25% pipéridinelDMF H2N
4) Fmoc-Cys -S(Fm)-OH, HOTU, o FmocN CO2H
HOBt, DIEA, DMF
3) 50% pipéridine/DMF, 5% TIPS e






Hoet, DIEA, DMF Tyr—N N...4_Phe_Leu
3) 25% pipéridine/DMF Me O
4) 90% TFA, 5% H20, 5% TIPS O
n 1 ou 2,
ratio diastéréoisomérique 4060
Schéma 14. Synthèse d’une chimiothèque d’analogues de Leu-Enképhaline
incorporant un mime de type BTD.
C
pré
sent sur la chaîne latérale, ce dernier attrappera l’ion N-acyliminium alors que, dans le
cas contraire, l’ion sera attrappé par l’azote de l’amide de l’avant dernier résidu du
peptide.
De plus, une stratégie de synthèse permettant d’incorporer le mime BTD
directement au peptide en construction sur support solide a été mise au point
dernièrement (Schéma 14). Un des concepts clés de cette méthodologie réside en
l’utilisation des acides aminés w-carboxaldehyde N-méthylés, pour contrer la
formation d’hémiaminales lors de la formation de la thiazolidine. Ainsi, onze
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analogues bicycliques de la Leu-Enképhaline N-méthylés ont pu être synthétisés et
examinés pour leurs affinités liantes à différents récepteurs opioïdes. L’avantage
d’utiliser une méthodologie sur support solide a été démontré en indiquant que
chaque analogue de la Leu-Enképhaline avait été synthétisé en douze étapes et ce, en
seulement deux jours.
Notre méthodologie de synthèse de mime peptidique macrocyclique ainsi que
d’acides aminés azabicycloalkanone possède l’avantage d’utiliser des blocs de
construction semblables. Il est donc facile d’imaginer que la méthodologie pourrait
être adaptée à une méthodologie de synthèse sur support solide (Schéma 15). À
première vue la synthèse de mimes macrocycliques sur support solide semble
possible, mais réside surtout dans la réalisation de la fermeture de cycle par métathèse
d’oléfines dans des conditions hétérogènes. Bien que les rapports de RCM sur des
substrats immobilisés sur un support solide sont beaucoup moins nombreux cette
demière méthodologie est maintenant utilisé avec un certain succès. Notablement,
des mimes du peptide oxytocine ont été mis au point en utilisant la méthodologie de
RCM sur support solide.5 L’oxytocine est un peptide cyclique constitué de 9 acides
aminés et possède un pont disulfure entre les cystéines en positions 1 et 6 formant un
macrocycle de 20 membres. Puisque le temps de demi-vie de l’oxcytocine varie entre
2 et 5 minutes, les chercheurs ont tenté de ralentir le métabolisme du peptide en
remplaçant chaque atome de souffre formant le macrocycle par une unité méthylène
ou méthine. Ainsi des peptides comportant des macrocyles de 20 à 22 membres ont
été synthétisés sur support solide en remplaçant l’acide aminé cystéine par des unités
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allylglycines ou homoallylglycine lors de la synthèse du peptide et en effectuant
ensuite la fermeture de cycle par métathèse d’oléfines toujours sur support solide.
Bien que thérapeutiquement moins actifs, ces analogues d’oxytocin ont montré leur
utilité en ayant un temps de demie-vie de 24 minutes dans des tissus de placenta
comparativement à 4 minutes pour l’oxytocine.
I 1) 25% pipéridinelDMF O
2) Fmoc-Phe-OH, HBTU, HS
HOBt, DIEA, DMFJ. 0—C\ Phe—Leu-...:.: +
FmocHN 3)25% pipéridine/DMF H2N
4) Fmoc-Cys -S(Fm)-OH, HBTU, Q FmocN CO2H
HOBt, DIEA, DMF Me3) 50% piridine/DMF, 5% TIPS
H H







2) Fmoc-Tyr-(Ot-Bu)-OH, HBTU, I
HOBt, DIEA, DMF TyrN Phe-teu
3) 25% pipéridine/DMF Ile O g
4) 90% TFA, 5% HO, 5% TIPS
n =1 ou 2,
ratio diastéréoisomérique 40:60
Q = résine de Wang
Schéma 15. Synthèse sur phase solide de peptides comportant soit un mime
macrocyclique soit un mime bicyclique.
5.2 Synthèse de mimes peptidiques sur support solide
Afin de prouver que la méthodologie pouvait être adaptée à une synthèse sur
support solide, nous avons donc choisi de synthétiser un hexapeptide constitué
d’acides aminés possédant des chaînes latérales non-fonctionnalisées comme la
leucine et la valine et où les acides aminés en position 3 et 4 seraient substitués par un
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dipeptide macrocyclique. La synthèse a donc débuté en couplant la fmoc-Val-OH à
la résine de Wang6 en utilisant le TBTU7 comme agent de couplage et le HOBt8
comme agent suppresseur de racémisation (Schéma 16). Le groupe protecteur fmoc
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Schéma 16. Synthèse d’un tétrapeptide dioléfinique.
a ensuite été enlevé en utilisant un mélange constitué de 20% pipéridine dans le DMf
et la Fmoc-Leu-OH a ensuite été couplée en utilisant les conditions citées
précédemment pour obtenir le dipeptide 88 sur support solide. La même séquence a
été utilisée pour coupler la N-(Fmoc)homoallylglycine pour obtenir le tripeptide sur
résine 89. Contrairement à la méthode utilisée en solution, l’installation d’un groupe
2,4-diméthoxybenzyl sur l’amine terminal a dû se faire en deux étapes afin de
minimiser les doubles alkylations et pour obtenir un rendement quantitatif Le groupe
Cyclisation
transannulaire
m,n = 1 ou 2
(I
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Fmoc du tripeptide 89 sur résine a donc été clivé, puis l’amine libre a été traitée avec
2 équivalents d’acide acétique et un excès de 2,4-diméthoxybenzaldéhyde dans un
mélange 1:1 de dichiorométhane et de triméthylorthoformate.9 Après 3h d’agitation
le mélange a été filtré et lavé, puis traité avec une solution de NaBH3CN et agiter
durant une journée pour obtenir le tripeptide sur résine protégé 90. Le deuxième
acide aminé oléfinique, la Fmoc-HAgly-OH, a ensuite été couplée en utilisant le
HATU1° conm-e agent de couplage et la N-éthylmorpholine comme base pour obtenir
le tétrapeptide 91 sur support solide.
Avec le peptide dioléfinique 91 entre nos mains, la cyclisation par métathèse
d’oléfine a été tentée (Schéma 17). Lorsque ce dernier peptide a été traité avec une
quantité supérieure à celle utilisée précédemment” de catalyseur de Grubbs de
première génération, soit avec 50 mol %, le tétrapeptide macrocyclique correspondant
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Schéma 17. Synthèse d’hexapeptide macrocvclique à 10 membres par RCM.
0
Nous avons réalisé qu’une bonne agitation est essentielle au bon fonctionnement de la
réaction. Par la suite la chaîne peptidique a été allongée, premièrement en
déprotégeant la fonction amine terminale puis en couplant la Fmoc-Val-OH en
utilisant le T3TU et le HOBt comme décrit précédemment. Cette séquence
déprotection-couplage a été effectuée une fois de plus pour coupler la Fmoc-Leu-OH
pour obtenir l’hexapeptide sur support solide 93. Le peptide a été clivé de son
support par traitement avec de l’acide trifluoroacétique 95% dans le DCM. Toutefois,
lors de l’analyse par spectre de masse, on a pu constater que le groupe 2,4-
diméthoxybenzyl connu pour être labile en conditions acides n’était pas clivé avec
ces conditions de clivage. Une prolongation du temps de réaction, ni l’ajout
d’anisole’2 n’ont pas aidé le clivage du groupe Dmb.
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Puisque l’étape redoutée, la cyclisation par métathèse d’oléfines, a pu être
accomplie, la synthèse de macrocycles à neuf membres sur support solide a été tentée
(schéma 18). Les mêmes conditions citées précédemment ont été utilisées pour
synthétiser les hexapeptides sur support solide 95 et 96. Malheureusement, lorsque
les peptides ont été clivés de leur support en utilisant du TfA à 95% dans le DCM, un
mélange d’hexapeptides comportant une fonction amide protégé par un 2,4-
diméthoxybenzyl (97 et 99) et d’hexapeptides non protégés (98 et 100) ont été
































Schéma 1$. Synthèse d’hexapeptides macrocycliques à 9 membres par RCM.
5.3 Travaux futurs
Bien entendu, les travaux présentés jusqu’à maintenant ne représente que le
début de ce projet. Afin de mener à bien ce projet, deux facettes du projet devront
être optimisée. Tout d’abord, il faudra trouver des conditions permettant le clivage
simultané du peptide de son support et du groupe protecteur Dmb. Dans le cas où le
clivage du groupe Dmb s’avèrerait trop difficile, il pourrait être intéressant de
substituer ce groupe par un groupement plus labile en conditions acides comme le
methyl-3-indoyl qui est beaucoup plus riches en électron que le groupement 2,4-
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diméthoxybenzyl. En effet, il a été démontré que le groupe methyl-indoyl pouvait
être clivé d’un amide en utilisant seulement 1% de TFA.’3
Toutefois, comme présenté dans le chapitre précédent, le clivage du groupe
DMB n’est pas nécessaire pour effectuer la cyclisation électrophilique transannulaire.
La deuxième étape d’optimisation consisterait donc à transformer les macrocycles sur
support solide en azabicycles sur support solide en utilisant l’iode comme électrophile.
Bien entendu, la fonctionnalisation des azabicycles obtenus présenterait un autre
projet intéressant. En effet, la présence d’un lien carbone-iode peut amener plusieurs
idées pour fonctionnaliser les azabicycles. Bien que infmcteux à ce jour, le
groupement iodure pourrait être déplacé par un azidure qui serait ensuite réduit pour
donner une poignée supplémentaire pour la fonctionnalisation. Aussi, l’iodure
pouffait être déplacé par un ion cyanure pour donner un nitrile qui pourrait être réduit
ou hydrolysé pour obtenir un groupement aminomethyl qui pourrait servir à mimer
l’omitine ou la lysine. D’autres groupes pourraient aussi être introduit en utilisant les
récentes procédures développées afin de faire un couplage croisé impliquant des
centres secondaires halogénés.’4 De plus, l’iodure pourrait être éliminé donnant ainsi
un azabicycle plus rigide et pourrait permettre le marquage radioactif d’un peptide




Une méthodologie de synthèse de mimes peptidiques macrocycliques a été
mise au poiffi. Les mimes peptidiques macrocycliques de 8, 9 et 10 membres ont été
synthétisés en utilisant des dipeptides constitués d’allylglycine et d’homoallylglycine.
Les deux oléfines terminales présentent ont servi à cycliser le dipeptide en utilisant la
méthodologie de fermeture de cycles par métathèse d’oléfines. Lors de la synthèse, il
a été observé que l’utilisation du dipeptide possédant une fonction amide tertiaire
était essentiel pour que l’étape de RCM soit réussie avec succès.
C.
Les mimes dipeptidiques macrocycliques ont par la suite servi lors d’une
cyclisation électrophile transannulaire à former des mimes dipeptidiques
azabicycliques. En effet lorsque les mimes macrocycliques ont été soumis a
différents électrophiles comme de l’iode ou du bromure de phénylséténium, des
amino esters azabicyclo[6.5j- ou azabicyclo[7.5.0]alcanone ont été obtenus.
Lutilisation ou pas d’un groupement Dmb sur l’azote formant la fonction amide du
dipeptide a permis de donner différente stéréochimie sur les atomes de carbones
situés en tête de pont et portant l’iodure.
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Des résultats préliminaires concernant la synthèse de mimes peptidiques
macrocyliques ont été dévoilés. La stratégie, utilisant la résine de Wang comme
support polymérique, permet d’élaborer une chaîne peptidique comme on le fait en
synthèse peptidique sur support solide et d’insérer les différents acides aminés
oléfiniques nécessaires pour former les lactames de 9 et de 10 membres. Une fois
que les deux acides aminés oléfiniques ont été introduits, la fermeture de cyclique par
métathèse a permis de former la lactame et la synthèse de la chaîne peptidique a pu
être continuée par la suite. Toutefois, lors du clivage du peptide, le groupe protecteur
2,4-diméthoxybenzyl n’a pu être entièrement clivé par les conditions acides utilisées.
En plus d’avoir mis au point deux strategies de synthèse pour obtenir de
mimes peptidiques macrocycliques et bicycliques, un nouveau groupe protecteur
d’amines a été synthétisé. Ce groupement protecteur de type « safety-catch », le 9-(4-
bromophényl)-9-fluorényl, possède la stabilité de son cousin, le 9-phényl-9-fluorényl,
ainsi que la possibilité d’être clivé dans des conditions acides plus douces lorsque
requis. En effet, après avoir été activé par un couplage croisé avec la morpholine
catalysé par le palladium, le groupe protecteur peut être clivé en employant de l’acide
dichloroacétique. Les conditions douces utilisées ont aussi montré que les groupes
labiles en conditions acides comme l’ester et le carbamate tert-butylique pouvait être





Procédure générale d’ancrage sur la résine Wang La résine de Wang (3.00 g, 2.4
mmol), dans le DMF (15 mL), a été successivement traitée avec la Fmoc-Val-OH
(3.26 g, 9.6 mmol), le TBTU (3.0$ g, 9.6 mmol), le HOBt (1.30 g, 9.6 mmol) et avec
la DIEA (2.5 mL, 14.4 mmol). La résine a ensuite été agitée pendant 24 h, puis
filtrée, lavée (3 x DMF, 3 x MeOH, 3 x DCM) et séchée sous vide pour obtenir la
résine Fmoc-Val-Wang. Le chargement de la résine a par la suite été déterminé par
absoption UV du dibenzofulvene lors du clivage du groupement Fmoc conmie étant
de 0.43 mmollg.’5
Procédure générale de clivage du groupement Fmoc La résine fmoc-Val-Wang
(3.00 g, 1.29 mrnol) a été traitée avec une solution 20% vol. de pipéridine (15 mL)
dans le DMF et agitée pendant 30 mm, filtrée, traitée une seconde fois avec la
solution de pipéridine 20%, filtrée, lavée (3 x DMF, 3 x MeOH, 3 x DCM) et séchée
sous vide pour obtenir la résine H-Val-Wang.
Procédure générale de couplage sur la résine, méthode A La résine H-Val-Wang
(3.00 g, 1.29 mmol), dans le DMF (15 mL), a été succesivement traitée avec la Fmoc
Leu-OH (1.82 g, 5.16 mmol), le TBTU (1.66 g, 5.16 mmol), le HOBt (697 mg, 5.16
mmol) et avec la DIEA (1.35 mL. 7.74 mmol). La résine a ensuite été agitée pendant
24 h, puis filtrée, lavée (3 x DMF, 3 x MeOH, 3 x DCM) et séchée pour obtenir la
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résine Fmoc-Leu-Val-Wang. Un test de Kaiser négatif a indiqué un couplage
complet.’6
Procédure générale de couplage sur la résine, méthode B La résine Dmb-HAgly
Leu-Val-Wang (100 mg, 00$ mmol), dans le DCM (1.5 mL), a été succesivement
traitée avec la Fmoc-HAgly-OH (112 mg, 0.32 mmol), le HATU (122 mg, 0.32
mmol) et avec la la N-ethylmorpholine (61 .tL, 0.4$ mmol). La résine a ensuite été
agitée pendant 24 h, puis filtrée, lavée (3 x DCM, 3 MeOH, 3 x DCM) et séchée
sous vide pour obtenir la résine fmoc-HAgly-(Dmb)HAgly-Leu-Val-Wang.
Procédure générale d ‘ amin ation réductrice La résine H-HAgly-Leu-Val-Wang
(100 mg, 0.08 mmol). dans une solution 1:1 DCMltnméthylorthoformate (1.5 mL) a
été traitée avec le 2,4-diméthoxybenzaldéhyde (292 mg, 1.76 mmol) puis avec l’acide
acétique (9.0 j.tL. 0.16 mmol). La résine a été agitée pendant 3 h, filtrée, lavée (3
DCM), traitée avec une solution de NaBH3CN (111 mg, 1.76 mmol) dans une
solution 1:1 DCMltriméthylorthoformate (1.5 mL) et agitée pendant une nuit. La
résine a ensuite été filtrée, lavée (3 X DCM, 3 x MeOH, 3 X DCM) et séchée sous
vide pour donner la résine Dmb-Agly-Leu-Val-Wang
Procédure générale de cyclisation par métathèse d’oléfine La résine fmoc
HAgly-(Dmb)HAgly-Leu-VaI-Wang (50 mg, 0.040 mmol) a été chargée dans un tube
de verre 1$mmxl5omm muni d’un capuchon de teflon, traitée avec une solution de
DCM (5 mL). agitée orbitalement , chaufée à reflux, et traitée avec le benzylidène
bis(tricyclohexylphosphine)dichlororuthenium (catalyseur de Grubbs de première
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génération) (16 mg, 0.020 mmol). La résine a été agitée et chauffée à reflux pendant
trois jours, traitée avec du DMSO (71 iL, 1.0 mmol), agitée pendant 12 heures à
température pièce, filtrée, lavée (3 x DCM, 3 x DMSO, 3 x MeOH, 3 X DCM) et
séchée sous vide pour donner la résine macrocyclique.
Procédure générale de clivage de la résine Wang La résine Fmoc-Leu-Val-Wang
(5 mg, 0.004 mmol) a été traitée avec une solution 95:5 TfA/DCM (0.3 mL), agitée
pendant 30 min et filtrée. Le filtrat a été concentr. pour donner la fmoc-Leu-Val-OH.
Résine fmoc-Val-Wang (87) La résine titre a été synthétisée à partir de la résine de
Wang en utilisant la procédure générale d’ancrage sur la résine Wang. Le clivage de
la résine en utilisant la procédure générale de clivage de la résine Wang a donné la
fmoc-Val-OH: MS calculé pour C20H22N04: 340.2 (M}1), MS obtenu: 340.3.
Résine Fmoc-Leu-VaI-Wang (88) La résine titre a été synthétisée à partir de la
résine 87 en utilisant la procédure générale de clivage du groupe fmoc suivi de la
procédure générale de couplage (méthode A) sur la résine Wang._ Le clivage de la
résine en utilisant la procédure générale de clivage de la résine Wang a donné la
Fmoc-Leu-Val-OH : MS calculé pour C26H33N205: 453.2 (MH), MS obtenu: 453.3.
Résine Fmoc-HAgIy-Leu-VaI-Wang (89) La résine titre a été synthétisée à partir de
la résine 88 en utilisant la procédure générale de clivage du groupe fmoc suivi de la
procédure générale de couplage (méthode A) sur la résine Wang. Le clivage de la
résine en utilisant la procédure générale de clivage de la résine Wang a donné la
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fmoc-HAgly-Leu-Val-OH: M$ calculé pour C32H42N306: 564.3 (M1-I, MS
obtenu: 564.4.
Résine Dmb-HAgIy-Leti-Val-Wang (90) La résine titre a été synthétisée à partir de
la résine 89 en utilisant la procédure générale de clivage du groupe Fmoc suivi de la
procédure générale d’amination réductrice. Le clivage de la résine en utilisant la
procédure générale de clivage de la résine Wang a donné la Dmb-HAgly-Leu-VaI
OH: MS calculé pour C26H42N306: 492.3 (MH), MS obtenu: 492.3.
Résine Fmoc-HAgly-(Dmb)-HAgIy-Leu-Val-Wang (91) La résine titre a été
synthétisée à partir de la résine 90 en utilisant la procédure générale de couplage
(méthode B) sur la résine Wang. Le clivage de la résine en utilisant la procédure
générale de clivage de la résine Wang a donné la Fmoc-HAgly-(Dmb)-HAgly-Leu
Val-OH : MS calculé pour C38H51N407: 675.2 (MH-Dmb), MS obtenu: 675.4.
Résine j(E, 3$, 1OS)-3-N-(Fmoc)Amin o- 1-(2,4-dimethoxybenzyl)-2-oxo-
1,2,3,4,5,8,9,10-octa-hydro-1H-azocine- JO-carboxyl] -Leu-Val-Wang 92 La résine
titre a été synthétisée à partir de la résine 91 en utilisant la procédure générale en
utilisant la procédure générale de cyclisation par métathèse d’oléfines. Le clivage de
la résine en utilisant la procédure générale de clivage de la résine Wang a donné le
tétrapeptide comprenant la lactame de 10 membres correspondant : MS calculé pour
C45H56N409: 797.4 (MH). MS obtenu: 797.2.
Résine Fmoc-Leu-Val- j(E, 3$, 1OS)-3-N-(fmoc)Amino-1-(2,4-dimethoxybenzyl)-
2-oxo- 1,2,3,4,5,8,9,10-octa-hydro-1H-azocine- lO-carboxyt] -Leu-Val-Wang 93 La
Chapitre 5 105
C
résine titre a été synthétisée à partir de la résine 92 en utilisant la procédure générale
de clivage du groupe Fmoc suivi de la procédure générale de couplage (méthode A)
pour coupler la fmoc-Val-OH. Le groupement protecteur Fmoc a ensuite été clivé
puis la procédure générale de couplage (méthode A) a été utilisée pour coupler la
fmoc-Leu-OH pour donner la résine 93.
fmoc-Leu-VaJ- [(E, 3$, JOS)-3-N-(Fmoc)Amin o- 1-(2,4-dimethoxybenzyt)-2-oxo-
1 ,2,3,4,5,8,9,1O-octa-hydro- JH-azocine- 1O-carboxylJ-Leu-VaI-OH 94 Le clivage
de la résine 93 en utilisant la procédure générale de clivage de la résine, Wang a
donné l’hexapeptide 94 : MS calculé pour C56H77N6011 1009.6 (MH), MS obtenu
1009.4.
Résine Fmoc-Leu-Val- I(E, 3$, 9S)-3-N-(Boc)Amino- 1-(2,4-d imethoxybenzyl)-2-
oxo-2,3,4,5,8,9-hexahyd ro- 1H-azonine-9-carboxylJ-Leu-VaI-Wang 95 La résine
titre a été synthétisée à partir de la résine 8$ en utilisant la procédure générale de
clivage du groupe Fmoc, suivi de la procédure générale de couplage (méthode A)
pour coupler la fmoc-Agly-OH. Le groupement protecteur Fmoc a ensuite été clivé
puis la procédure générale d’amination réductrice et de couplage (méthode B) ont été
utilisées pour coupler la Fmoc-HAgty-OH. La procédure générale de cyclisation par
métathèse d’oléfines a été utilisée pour obtenir le macrocycle sur support solide. Le
groupement protecteur fmoc a ensuite été clivé puis la procédure générale de
couplage (méthode A) a été utilisée pour coupler la fmoc-Val-OH. Le groupement
protecteur fmoc a ensuite été clivé puis la procédure générale de couplage (méthode
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A) a été utilisée pour coupler la fmoc-Leu-OH sur la résine Wang pour donner la
résine 95.
Résine Fmoc-Leu-Val- t(3S,9S)-3-N-(Fmoc)Amino-1-(2,4-dimethoxybenzyl)-2-
oxo-2,3,4,7,8,9-hexahyd ro- 1H-azonine-9-carboxylJ -Leu-Val-Wang 96 La résine
titre a été synthétisée à partir de la résine 88 en utilisant la procédure générale de
clivage du groupe Fmoc, suivi de la procédure générale de couplage (méthode A)
pour coupler la fmoc-HAgly-OH. Le groupement protecteur Fmoc a ensuite été clivé
puis la procédure générale d’amination réductrice et de couplage (méthode B) ont été
utilisées pour coupler la Fmoc-Agly-OH. La procédure générale de cyclisation par
métathèse d’oléfmes a été utilisée pour obtenir le macrocycle sur support solide. Le
groupement protecteur fmoc a ensuite été clivé puis la procédure générale de
couplage (méthode A) a été utilisée pour coupler la fmoc-Val-OH. Le groupement
protecteur fmoc a ensuite été clivé puis la procédure générale de couplage (méthode
A) a été utilisée pour coupler la fmoc-Leu-OH sur la résine Wang pour donner la
résine 96.
Hexapeptides 97 et 98 Le clivage de la résine 95 en utilisant la procédure générale
de clivage de la résine Wang a donné les hexapeptides 97 et 98 dans un ration 9:1 par
LC/MS: MS calculé pour C55H76N6011 (97): 995.5 (MH), MS obtenu: 995.3, MS
calculé pour C46H65N609(98): $46.5 (MH), MS obtenu: $46.3.
Hexapeptides 99 et 100 Le clivage de la résine 96 en utilisant la procédure générale
de clivage de la résine Wang a donné les hexapeptides 99 et 100 dans un ration 9:1
Chapitre 5 107
par LC/MS : MS calculé pour C55H76N6011 (99): 995.5 (MH), M$ obtenu: 995.3,
MS calculé pour C46H65N609 (100): 846.5 (MH), MS obtenu: $46.3
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